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Eturauahssyöpä on länsimaissa hyvin yleinen sairaus, jonka esiintymistiheys kas-
vaa vuosi vuodelta elintason ja elinajanodotteen kanssa. Laajoista tutkimuksista
huolimatta eturauhassyöpä tuottaa edelleen huomattavia haasteita potilashoidolle,
tutkijoille ja yhteiskunnille. Eturauhassyövän rekurrentin muodon parantavan hoidon
puuttuessa sairaus säilynee intensiivisen tutkimuksen kohteena myös tulevaisuudessa.
Vaikka lukuisia yksittäisiä komponentteja tai reaktioteitä käsitteleviä tutkimuk-
sia on julkaistu, todellisia yrityksiä eturauhassyövän globaalin säätelytekijäprofi-
ilin muodostamiseksi ei ole tehty koko genomin laajuisella skaalalla. Tässä työssä
pyritään muodostamaan pohja tämän kunnianhimoisen haasteen toteuttamiseksi
hyödyntäen laskennallisia menetelmiä transkriptiofaktoreiden säätelykohtien ennus-
tamisessa ja säätelyverkkojen johtamisessa. DNase I hypersensitiivisyysinformaa-
tion ohjaama transkriptiofaktoreiden sijaintiriippuvien sitoutumismatriiseiden avulla
toteutettu skannaus suoritettiin usealla eri tavalla tuottaen katalogi mahdollisista
säätely-yhteyksistä.
Ennustetut säätely-yhteydet arvioitiin huolellisesti ja useita kehitelmiä alkuperäis-
estä menetelmästä esitettiin muodostaen vahvan ohjenuoran tulevien laskennallista
säätelytekijäprofiilinrakennusta hyödyntävien sovellusten käytettäväksi. Lisäksi jat-
kosovelluksena geeniekspressiodataa sovellettiin erottamaan säätelyverkko, joka on
läsnä ainutlaatuisesti vain LNCaP-solulinjan soluissa. Johtopäätöksenä genomin-
laajuiset laskennallista säätelytekijäverkkoa rakentavat menetelmät esitetään toimi-
vana mutta haasteellisena lähestymistapana, jolla kuitenkin on suunnattomia mah-
dollisuuksia sen sovellusen vuoksi solutyyppikohtaisten ja sairauskohtaisten sääte-
lyverkkojen profilointityökaluna.
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Prostate cancer is a highly common disease in the Western countries with its
prevalence growing every year with the standard of living and life expectancy. De-
spite extensive studies prostate cancer presents still considerable challenges to pa-
tient care, scientists and societies. As still no curing treatment exists for the recur-
rent form of the disease prostate cancer is likely to remain an intensive subject for
study also in the future.
Even though numerous studies exists that try to characterize individual compo-
nents and pathways of regulation, no real attempts have been made to characterize
the regulation profile of prostate cancer in a genome-wide level. This thesis forms a
basis for this ambitious feat by using computational methods in transcription fac-
tor mediated regulation prediction and network inference. DNase I hypersensitivity
guided genome scanning with transcription factor specific position weight matri-
ces is performed in several manners, producing a catalogue of putative regulation
connections in LNCaP cells.
The predicted connections are subjected to thorough evaluation and several appli-
cations of the first method are presented, forming a strong set of basic guidelines for
computational prediction based regulome assembly for future studies. In addition, as
a further application gene expression data is applied to selectively extract a subnet-
work of regulation present exclusively in the studied LNCaP cells. As a conclusion
the genome-wide computational regulome assembly is presented as a functional but
challenged approach with enormous potential due to its possible applications as cell
type or disease specific network profiling tool.
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TERMS AND DEFINITIONS
ChIP-seq Chromatin ImmunoPrecipitation sequencing, a technology to map
the binding sites of DNA binding proteins
AR Androgen receptor
ARE Androgen Response Element
BPH Benign Prostate Hyperplasia
cDNA Complementary DNA, synthetized from mRNA
CRPC Castration Resistant Prostate Cancer
DHT Dihydrotestosterone
DNA Deoxyribonucleic acid
DNase I -seq Sequencing technology for DNase I enzyme hypersensitive regions
to locate areas of active regulation in genome
GEO Gene Expression Omnibus
GnRH Gonadotropin-releasing hormone
IGV Integrative Genomics Viewer
LNCaP Androgen positive prostate cancer specific cell line
mRNA Messenger RNA, RNA molecule carrying transcribed genomic infor-
mation
NGS Next Generation Sequencing
PCa Prostate Cancer
PCR Polymerase Chain Reaction
PSWM Position Specific Weight Matrix, identical to PWM
PWM Position Weight Matrix, identical to PSWM
RNA Ribonucleic acid
SNP Single Nucleotide Polymorphism
TF Transcription Factor
11. INTRODUCTION
Biology is a seemingly never ending field for research. Only a small fraction of
the complicated function of a cell is currently understood. Even though years of
research have uncovered a plethora of detailed information of the function of a
cell the underlying factors that control it such as mechanisms of transcriptional
regulation are not at all fully characterized. On a very basic level DNA is the starting
point to understanding cell’s behavior since it is used to produce the functionality of
the cell through proteins. The question how the genotype of an individual manifests
as a phenotype is an enormously interesting and relevant in order to understand
the delicate machinery that keeps the cell in homeostasis - and what disturbs the
balance. Thus cellular behaviour arising from the genotype is inseparably related to
human diseases such as hereditary diseases, immunological diseases and cancer.
Due to the formidable complexity of the cell traditional experimental methods of
molecular biology have started to give room to a new type of research. As technology
advances huge masses of measurement data from inside the cell have become avail-
able - a fact which is currently changing the entire field of life sciences permanently.
With the high-throughput technologies which produce these vast data collections in
relatively short time the researchers are able to see the cell’s genomic and transcrip-
tomic features at a whole new level. However, the new possibilities bring also new
challenges: information has to be extracted from the mass of measurement data.
This is possible using sophisticated mixture of computational methods based on
mathematics and signal processing encoded into computer programs.
The fields of computational biology, systems biology and bioinformatics make use
of the data through computational methods aiming to increase our understanding
of complex biological phenomena and to improve the quality of life we live. These
approaches have already proven to be invaluable in fighting complicated and wearing
diseases such as cancer. Cancer as one of the most common causes of death in
developed countries provides a significant challenge to researchers and medical care
due to its difficult treatment and relatively high mortality. Cancer also presents a
growing problem with already over 14 million yearly cancer cases in the world and
estimates of doubled cancer burden during the next two decades [1]. These facts
make cancer a serious threat to individuals and to society, and make cancer research
one of the most important fields of research.
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In a cancer cell the normal control mechanisms of at least cell division and death
have become disturbed. However, as the cell possesses numerous ways to control
these functions it is very difficult to determine the reason causing the observed
behavior. One possible cause is that something has gone awry in the cell’s gene
expression control system. The regulation of gene expression is mostly performed
by specific molecules called transcription factors (TFs) but also many other factors
take part in the process. In a normal cell the regulation machinery makes sure that
each protein is produced at a right time, rate and quantity. Since the machinery is
networked very tightly together many regulation connections affect and complement
each other which makes it is very challenging to find a malfunctioning part using
traditional biological experiments.
To respond to the challenge of understanding ever more intricate cellular pro-
cesses, new generation of measurement technologies has emerged and matured dur-
ing the last decade to a level where genome-wide data generation is routine-like and
relatively inexpensive experiment, producing vast amounts of measurement data.
Genome and transcriptome profiling and gene regulatory elements are basic targets
for such experiments and also advanced applications grow more common each year.
The data explosion in biology desperately craves also better computation power and
analysis tools, which are being actively developed by an international community
of researchers. It has become clear that there is no turning back: as biology is be-
coming more and more a data-driven science it depends heavily on computational
analysis and information technology. While this progress presents major challenges
in data management, control and interpretation, the new techniques both biologi-
cal and computational provide enormous potential for better science, fundamentally
better understanding of biology and ultimately, better quality of life.
To make use of this potential this thesis aims to give new insight into gene reg-
ulation in the context of cancer. The presented work makes use of state-of-the-art
systems biology methods to construct a network of gene regulation in prostate can-
cer cells. The network is created by calculating predictions of TF binding sites to
the genome and inferring regulation connections from these sites according to prox-
imity of putative regulated elements. These binding site predictions are then filtered
for inaccessible sites of the DNA using several different approached, and finally the
regulator-target pairs are connected to one large global network of prostate cancer
regulation. This novel network could have the potential to pinpoint new connections
and subnetworks of regulation relevant to origin and progression of prostate cancer.
In addition, the developed method is not application specific and on the contrary can
be widely applied to various different network modeling tasks providing an excellent
start point for further biomedical studies.
32. THEORETICAL BACKGROUND
2.1 Regulation of Transcription
Transcriptional regulation is a multistage process where a horde of different molecules
interacts together directly and indirectly to produce a correct regulation output in
each varying situation. However, in order to understand the mechanisms of regula-
tion DNA structure, packaging and modifications must first be understood.
2.1.1 DNA packaging
DNA does not drift idly and alone in the nucleus of a cell. Rather, normally it is
packaged tightly around protein complexes consisting from histone proteins which
are as part of the histone protein family one of the most common proteins in eu-
karyotic cells. The histone proteins form octameric histone complexes that take
a disc-like shape illustrated in Figure 2.1. As a histone complex rounds up DNA
together they form a larger complex called nucleosome which forms a fundamental
unit of DNA packaging. The DNA strand is coiled around the histone complex 1.7
times in each nucleosome which corresponds to 147 base pairs. The adjacent nucle-
osomes are connected by a string of linker DNA that allows flexibility in packaging
the structure. Along with other DNA binding chromosomal proteins the forming
structure is referred to as chromatin. Chromatin can be packaged even further
to different degree according to the cells needs through formation of complicated
coiled-coil structures.
A loosely packaged form of the chromatin is so called ’beads-on-a-string’ structure
where the linker DNA is fully stretched out. This is illustrated on the right in
Figure 2.1. A much tighter packaging is achieved when the nucleosome complexes
curl up and form a tight meshwork structure. This packaging of the chromatin
increases the density of DNA remarkably and enables the small nucleus to contain
huge macromolecules such as chromosomes: the most packaged form of DNA when
a whole chromosome condenses, for example, in cell division, packs the DNA 10,000
times shorter than its fully extended form.
In addition to saving space, through packaging some areas of the chromatin can
be condensed to an very dense, inaccessible bundles called heterochromatin. The
DNA in heterochromatin is purposefully blocked. The blocking function of hete-
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Figure 2.1: Histones in a complex, nucleosomes and "beads-on-a-string" conformation [4]
rochromatin largely assists cell differentiation when unwanted areas of the genome
are effectively repressed or silenced: for instance, a liver cell has many functions that
a neuron does not, and it is also of vital importance for the liver cell to suppress
expression of all neuronal features coding genes in order to function like a proper cell
of the liver. Heterochromatin is a cost-effective way to implement this functionality
that helps the cells in differentiation. [2]
Chromatin can be rapidly modified by special proteins called chromatin-remodeling
complexes which are ATP-driven machines functioning to condense or unpack chro-
matin. Chromatin is also modified by proteins performing histone modifications
such as acetylations, methylations and phosphorylations. The modifications take
place in tails of the histones and have a multitude of functions, many still unknown.
A vast variety of different modifications targeting different subgroups of the histone
tail exist and the effects they mediate are known to be very important to the cell:
the modifications can change the electrostatic properties of nucleosomes resulting
in packing or unpacking of chromatin, they affect the binding of chromatin factors
and they may also promote or repress processes like gene expression [3] In addition,
histone modifications have a crucial role in epigenetic heritance where non-DNA
information is passed to progenitor cells. [2]
2.1.2 Gene Regulation
A decade ago almost beyond our reach, the uncovering of an organisms genome
is nowadays a fairly simple task thanks to modern high-throughput measurement
technologies. However, even when provided with the information of an organisms
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detailed DNA structure one does not in practice achieve any closer to understanding
how such complex organisms as humans are built: even though all somatic cells
in our body are identical from their genomic contents they form a huge variety
of different tissues. In order to form a multicellular organism the different cells
must control the production of their proteins in highly controlled and specialized
manner: to be able to ensure the exact function of the cell the expression of a
gene and eventually production of the corresponding protein cannot be random
processes. Indeed, regulation of gene expression takes place in every phase along the
process starting from DNA and ending in protein synthesis, function and ultimately
degradation. This complicated and fine-tuned machinery allows organisms to form
complex structures like tissues and organs, and enable them to perform the tasks
that belong to what we consider life. [4]
Eukaryotic gene expression is a subject to several different control phases visu-
alized in Figure 2.2. One important regulation step occurs already when a gene
is described into RNA. Another controlled process that effects the expression and
thus the behavior of the cell is post-transcriptional modification of messenger RNA
(mRNA) which is governed by delicate protein machinery that performs splicing,
capping and transport tagging functions[5]. mRNA transport and localization are
also examples of controlled processes: RNA molecules need to be delivered to right
ribosome complexes to enable correct protein production. Before translation can
occur processes that force RNA to be degraded can take place and thus affect the
expression of the gene. Also mRNA translation of the surviving mRNAs especially
at its initiation stage is strongly controlled by a horde of pro-translational factors
that with the ribosome subunits form a translation initiation complex. Finally, af-
ter translation the activity of the produced protein is also a subject to regulation
through different post-translational modification processes. Finally, after the im-
mense task of producing the functional protein its degradation frankly is another
important regulatory process. Efficient degradation of proteins is vitally important
since many cellular processes need to react quickly to changes in the environment
and cell’s internal state. On the other hand a protein that is consistently needed
in the cell can be maintained at sufficient levels with reduced degradation rate that
allows protein pileup and thus desired functionality. [4]
The signal that initiates different regulation control mechanisms may rise from
various locations or factors. Based on its origin the regulation of expression can
also be divided to extrinsic and intrinsic control. Many extracellular signals such
as secreted signaling proteins, other small molecules and physiological factors like
temperature, pH and oxygen concentration can affect the expression of a gene. All
these signals affecting the cell induce relatively rapid but often temporary or at least
reversible changes in gene expression. Through this nature of extrinsic control the
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Figure 2.2: Steps of regulation during gene expression to proteins [4]
reaction mechanisms of the cell can have very significant effects on the cell itself,
its neighbors or even the entire organism through changed levels of gene expression
resulting in, for instance, hormone production and release. Hormone secretion is
one way of passing information in the organism to guide and coordinate the function
of other cells to perform vital functions like maintaining homeostasis. Thus with
extrinsic gene expression regulation the cells are able to communicate and adjust
their behavior according to changing needs. [6]
While it is evident with certain exceptions that the genome of a cell does not
change when a cell differentiates, the cell needs a way to permanently change its
patterns of gene expression to become truly different than its progenitor. In addition
to TF induced control this can be achieved also through intrinsic control of gene ex-
pression. This means in practice modification of DNA mainly through methylation
and modification of chromatin most commonly methylation or acetylation with his-
tone modifications. These changes have the potential to alter DNA structure is such
a way that access to DNA and thus to particular genes may be gained or blocked.
This form of so called epigenetic or non-genomic regulation is very important in cell
differentiation. As the use in differentiation hints these modifications are typically
more stable than regulation conditions induced by TF binding. However, they are
not fixed and can be changed which is a common event for instance in some cancer
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types. [6]
2.1.3 Transcription Factors and Regulation of Transcription
One of the most important steps of gene expression regulation occurs already at
DNA level: the transcription of DNA into RNA poses a major control point in the
whole gene expression process. Regulation of transcription is not only efficient but
also versatile place for expression control. The efficiency is mostly due to the re-
sources saved by the cell: if the expression of a gene needs to be lowered or stopped
the most energy and building materials are saved when the cellular workflow leading
ultimately to protein synthesis is arrested at the first possible stage. On the other
hand the complexity of transcriptional control allows a wide-ranging collection of
different possible states of expression in a cell and enables also fast and power-
ful response to stimulus. These features of transcriptional regulation are achieved
through use of transcription factors (TFs) to control which genes are transcribed
and in which amounts. [4]
Transcription factors are proteins or protein complexes that share the common
feature of possessing a DNA binding domain. The domains of different factors are
sequence specific and thus enable the TFs to bind different areas of DNA called
TF response elements. Unlike, for instance, the restriction enzymes that recognize
and cut DNA at their specific target site and that site only, a TF binds a much
wider range of response elements: the elements that match the domain of the TF
more accurately bind with higher affinity while more mismatches containing response
elements result into weaker binding. This mechanism allows much stronger control of
transcription since it allows not only TF specific regulation but also binding affinity
based regulation with each TF. This results into a complex mixture of regulating
factors that bind response elements with different speed and stability allowing the
gene expression to be adjusted with very fine tuned steps if needed. [7]
TFs were traditionally thought to bind to gene promoter and that way regulate its
expression by either promoting the formation of transcription pre-initiation complex
or repressing it. After detailed studies the promoter area of a gene is usually divided
to core promoter region which corresponds to the binding site of the RNA polymerase
II complex, and to promoter-proximal region which contains TF binding regions
some 1000 nucleotides upstream of the core promoter. In addition, already for some
30 years it has been known that TFs regulate the expression of genes also through
other sites in the DNA. These sites can be located even hundreds of thousands of base
pairs upstream of the promoter sequence and they take part in regulation through
long loops in the DNA which bring the bound TFs to proximity of the promoter.
These far-upstream elements are divided into enhancers, silencers, insulators and
tethering elements. Silencers are sequences where repressor TFs bind to hinder
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the transcription process through interactions with the promoter binding elements
or enhancers. Insulators are chromatin elements that bar access from regulating
elements to certain area, thus insulating the influence of different signals, whether
positive or negative. Tethering elements are usually located near to promoter region
of the cell and help to guide the looping enhancer elements to right gene’s promoter.
[8]
The most important far-upstream regulatory elements are the enhancers which
contribute positively to the transcription of genes. Enhancers and their bound TFs
have a key role in transcription initiation. Enhancer sites are short, some hundred
nucleotide long sequences that function as docking areas for specific transcription
factors. One enhancer region often contains not one but a cluster of response el-
ements of different TFs. Interactions between these enhancer TFs, with other far-
upstream elements and with the promoter elements results in a combinatorial effect
that has the ability to produce accurate expression patterns which are important,
for instance, in many developmental processes. [8]
In addition to the spatial binding patterns of TFs, the regulation has also a
temporal nature. It has been shown that at least in some cellular processes the
binding of TFs to enhancer regions is time dependent even though the levels of
the TF remain constant the whole time. This suggests that the time-dependent
binding of TFs is not only controlled by the expression level of the TFs but also by
more complicated mechanisms. The temporal binding is thought to be regulated by
binding affinity to the sites response element and also number of response elements
which can make the binding more sensitive to small changes in TF concentration.
[8]
2.1.4 Gene Regulatory Networks
The previous discussion of regulation of one gene already reveals the nature of more
general gene regulation: the gene is controlled by TFs which in turn are sensitive
to other TFs and regulation mechanisms. In other words, cell-wide transcriptional
control is far from being an independent process. Rather, the regulation connections
typically form a network that controls the expression of genes in a complicated
manner. Typically the TF control mechanisms for functional entities which can
be quickly activated: for example, one signal can activate several TFs to regulate
their targets in a differential way. This means the regulation enables the mechanism
of cellular responses which result in cascade-like changes in expressions of multiple
genes. This type of regulation allows the cell to react to changing conditions or
needs. Ultimately, together the different TF-target connections form a cell-wide
regulation network with distinct global and local topology. [9]
Studies indicate the global topology of the gene regulatory network shows unex-
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pected connection patterns. Instead of normally distributed number of regulation
connections between elements it appears that nodes with high number of regulation
connections are relatively common. These so called hubs are often more conserved
than other genes and also have a role in more vital functions of the cell. The gene
regulatory networks are often classified as critical because of their specific topology
and resulting function. Emergent phenomena are frequently observed in critical net-
works. In the context of gene regulatory networks this means the regulome’s ability
to form complicated and in long term unpredictable behavior. [10; 11]
Also the local structures of gene regulatory networks are of great importance to
the cell. Local networks of a few genes can form numerous network structures or
motifs that can implement many surprisingly complicated functions. For instance, a
structure resembling a toggle-switch exists and possesses an important role in several
cell fate determining processes. In the toggle-switch structure two genes mutually
repress each other. Often the initial low expression of both genes can be turned
into domination of the other TF by some external stimulus. The TF that gains the
dominance over its switch pair leads to activation other TFs possibly resulting in
a lineage fate choice and differentiation [11]. Other examples of interesting local
motifs are feedforward loops and negative autoregulation. Feedforward loops have
several different topologies and are capable of implementing regulatory ’logical gates’
that produce AND and OR type regulation functions. Feedforward loops can also
produce pulse-like dynamics and thus periodical gene expression. This is of special
importance to many cellular functions related to detecting an external signal and
provide an energy saving solution since the detector gene is produced more rarely in
periodic pulses. In addition, negative autoregulation, although being an extremely
simple one gene motif, has interesting features as it is able to tune the expression of
a gene to a steady level by a concentration dependent threshold of self-repression.
These common local motifs are illustrated in Figure 2.3.
As hinted by the function of toggle-switches, gene regulatory networks have a
vital role also in early development of an organism as they control the spatial local-
ization of different cellular functions in an embryo. Regulatory networks also govern
processes like pluripotent stem cell differentiation and eventually formation of differ-
ent tissues [11]. Because all organism’s cells originate from a common ancestor, the
fertilized egg, it can be stated that the underlying global transcriptional regulatory
network of all possible regulation connections in a cell is somewhat static. This
arises from the locations of the response elements to different TFs which remain
unchanged in all unmutated somatic cells of an individual. The actual functional
regulation network of a given cell type is a specific instance of this global putative
connection network and it defines the detailed cell type and state characteristics.
This is completed through competitive binding to overlapping response elements
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Figure 2.3: Common local network motifs: one type of feed-forward loop, self-repressing
gene and a toggle-switch
resulting in differential regulation [12], and by physical changes in the DNA struc-
ture and packaging like formation of heterochromatin to permanently silence certain
genes leading to unwanted progression lineages [3]
Often a specific part of the global network is a subject of interest for researchers.
For instance, numerous pathways have been annotated to databases like KEGG
(Kyoto Encyclopedia of Genes and Genomes) and several others, containing parts
of gene expression networks in those annotations. Also networks spanning from
single regulating factors such as the subnetwork of androgen receptor (AR) are
typically a target for studies. For example, the mentioned AR subnetwork has been
intensively studied and its characteristics have been presented in many publications
due to its crucial role in prostate cancer [13]. The network models can provide help
in characterizing dynamic behavior of a system as interactions can be perceived from
the network connections.
2.2 Pathology of Cancer
Cancer is a serious, often life threatening ailment to the patient and has also a
significant societal impact due to its costly treatment and growing incidence due
to improving standard of living and prolonging life-expectancy. In this chapter a
short introduction to cancer as a disease is given. Furthermore, prostate cancer is
discussed in more detail as it is of special interest in the context of this thesis. Lastly,
cell line models and the validity of cell lines as models of a disease is discussed.
2.2.1 Cancer as a Disease
In the world of the cells, death is a natural part of life. The cells of an organism form
a fine tuned functional entity based on collaboration and mutual benefit: the cells
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share resources and keep each other alive while performing their given tasks which in
turn enables the continuity of their existence. One could say, the cells work together
for greater good, which in this case is the independent life of the individual they
form. In this collaborative effort should a cell come across some misfortune leading
dealing irreparable damage to its function the cell as its normal response seemingly
selflessly gives its life in order to avoid causing further injury to its neighbors and,
ultimately, to the whole organism. This controlled suicide mechanism of the cells
called apoptosis enables the continuous life of an individual despite environmental
hazards and stochastic processes of the physical world.
Mutations are a driving force of evolution and ensure the development and adap-
tivity of every species. However, mutations in the genome of an individual cell occur
randomly due to the purposefully imperfect DNA replication and repair machinery
the cell possesses. Given the human genomes immense size compared to gene cod-
ing regions it may often be that an occurring mutation has no effect on the protein
manufacturing of the cell and induces no changes in the cells function. However,
it has been shown that there is a link between mutagenesis and carcinogenesis (the
generation of cancer). That is, should the mutation occur in some protein coding
sequence or, for example, in a regulatory element, the effects are rarely positive.
Rather, the mutation may result in loss of function of a protein domain, result in
misfolding of cellular structures, illogical regulation patterns or any combination of
these. A normal cell however has the ability to deal with these misfortunes through
apoptosis, and make sure the harmful mutation is not passed along to the cells
progenitors. [14]
One mutation does not cause a cancer. This is quite evident just by inspecting
the average mutation rate in the human genome. Due to replication and error
correction machinery’s imperfect accuracy it has been estimated that approximately
10−6 mutations occur per gene with every DNA replication. As an average human
experiences about 1016 cell divisions in their lifetime it seems that the number of
occurring mutations during a persons life is tremendous. From this inspection it
seems clear that an individual mutation cannot be the cause of a cancer - we simply
would not be able to exist if every one of these frequent mutations was lethal.
Instead, often a process of tumor progression is considered: initially a harmless
change in the cell eventually transform the cell into an actual cancer. [14]
In addition to genetic mutations the piling up in the cell’s DNA also epigenetic
patterns have been shown to play a role in tumor progression. A normal cell trusts
epigeneticly inheriting histone modifications to enforce similar structure of hete-
rochromatin and DNA methylation in its progeny to ensure that critical genes stay
silenced. In similar manner, genes controlling tumor suppression may end up being
silenced by heterochromatin during tumor progression. These epigenetic modifica-
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tion patterns are transmitted to the daughter cells as surely as the genetic mutations
and may have significant impact in the development of the tumor. [14]
Even though cancer promoting mutations are generally regarded as highly nega-
tive and harmful events, from the perspective of the mutated cell the effect is quite
opposite. The mutation in practice means the cell has gained an advantage over
its peers, giving it seemingly unnatural powers such as superior nutrition intake,
growth rate or immortality. This can be pictured as a process of microevolution
where mutations give the cell an evolutionary advantage over its competitors. With
the emerged edge in competition the cell quickly starts to dominate its surroundings.
This is generally regarded as the creation of a benign tumor. Should the cell obtain
a fitting series of mutations resulting in more malfunctioning cellular controls it is
possible that the tumor turns malignant and starts to invade adjacent tissue. At
this stage the cell’s internal safeguard mechanisms have profoundly failed due to the
stockpiled mutations and the cells cannot contain themselves anymore - a cancer
has been born. The evolutionary advantage of the original mutated cell has granted
the tumor dominance over its former collaborators but instead of resulting in an
advantage for the organism the growing population now threatens the function of
the tissue and life of the entire individual. [14]
2.2.2 Prostate Cancer
Prostate cancer presents an ever growing concern to the western world. It is the
most common male cancer and second most common cancer related cause of death
just after lung cancer, with over 230,000 estimated new cases and almost 30,000
deaths in 2014 in the United States alone. However, even though estimates state
that 1 out of 7 men are expected to be diagnosed with prostate cancer during their
life only approximately 1 man of 36 will eventually die from the cancer. This is due
to prostate cancer being a disease of elderly men with 6 of 10 cases being diagnosed
in men in their mid-sixties or older. The advanced age of the patients combined with
modern treatments mean that many patients will die with the cancer but not from
it. An even more common prostatic change than the cancer itself is the so called
Benign Prostatic Hyperplasia (BPH) which means benign increased proliferation of
the prostate gland cells: even 90% of men in their eighties are estimated to exhibit
BPH [15]. While BPH can develop into prostate cancer it is most often harmless
and will not affect the patients quality of life. [16]
The male sex characteristics arise mainly from androgen hormones’ effects in
the body. Testosterone, secreted by the testes is the principal androgen that is
transported in the body through blood circulation in albumin and globulin com-
plexes. Testosterone is converted to dihydrotestosterone (DHT), a far more reactive
androgen while entering the prostate cells. DHT has a high affinity for the an-
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drogen receptor (AR) which is a nuclear receptor protein composed of activating
domain, ligand-binding domain and DNA-binding domain formed of two zinc finger
motifs. The binding of androgens induces a conformational change in AR resulting
in phosporylation of the receptor and release of heat-shock proteins attached to the
basal state receptor. The changes enable formation of AR homodimer complexes
which are eventually able to interact with Androgen Response Elements (AREs) in
the DNA. The binding of the AREs results in changes in gene expression ultimately
stimulating the prostate cell proliferation. The principle of AR activation pathway
is pictured in Figure 2.4 [17]
Figure 2.4: Androgen receptor response to androgen stimulation
As mutations take place in the prostate tissue and some cells start to show can-
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cerous behavior the cells remain still under strong androgen based growth control.
This is why androgen ablation therapy, that is, the artificial lowering of the androgen
levels in the body is typically used in the treatment of first stage prostate cancer.
The cancer cells respond to the deprivation of growth-inducing androgens by regress-
ing and the advancing disease halts. With the androgen ablation therapy the first
stage prostate cancer is treatable and generally yields very good results. The effects
of androgen deprivation were first observed more than 40 years ago when Charles
Huggins was able to show that orchiectomy, that is, the removal of the testes had
the potential to halt advancing prostate cancer. Currently the androgen ablation
is achieved by so called chemical castration using gonadotropin-releasing hormone
(GnRH) agonists and androgen antagonists instead of the physical castration treat-
ment.[17]
The mere androgen deprivation is not enough, however. Without additional treat-
ment the cancer eventually becomes androgen independent or and symptoms of the
disease return. Time span of this recurrence varies from several months to several
years and it is observed in most patients whose treatment has failed in decimating
the cancer tissue in the first stage of the cancer by androgen deprivation and ad-
ditional methods such as radiation therapy and surgical operations. The recurring
androgen independent or so called castration resistant prostate cancer (CRPC) is a
far more serious form of the disease. A metastasized CRPC remains still an uncon-
quered challenge to medicine since currently only palliative treatments exist - the
disease unstoppably leads to the patient’s death.
Reasons behind the recurrence are still not thoroughly known. It has been shown
that despite the androgen deprivation therapy the CRPC cells contain small but
detectable levels of androgens which can be enough to induce AR mediated cell
proliferation and recurrence of the cancer [18]. In addition, the recurrent form of
the cancer seems to show high levels of androgen and elevated levels of AR co-
activators putting emphasis to androgen hypersensitivity theory where even tiny
levels of androgens are enough to launch the AR mediated response [19]
Prostate cancer has been studied intensively and various mutations and chromo-
somal rearrangements such as gene fusions have been reported as contributing or
even driving factors in prostate cancer development. One factor deserving special
attention due to its crucial role in the progression of the cancer, however, is the
androgen receptor - indeed, several scientific publications have studied the role of
AR and its regulation targets in various conditions. However, a broader mapping of
gene regulation in prostate cancer is another issue, and to our knowledge no previ-
ous work on global prostate cancer specific regulation profiling has been published.
This fact makes prostate cancer an interesting subject for this study and adds to
the potential of eventually discovering novel pathways of differential regulation in
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prostate cancer.
2.2.3 Cell Line Models
There are many problems with cell cultures obtained from human tissue. First of
all, since the environment in the culture is drastically different to that in the tissue
due to loss of 3D structure, changed nutrient flows and attachment to surrounding
tissue, the cells are very hard to grow. In addition, even growing cells eventually
stop dividing as shortening of telomeres or other issues activate cell cycle arrest,
meaning in practice that the culture becomes superfluous. On the other hand, the
cost of obtaining tissue samples measured in time, money and patient comfort are
considerable. An answer to these issues is provided by using special cell line models
in cultures and in the following experiments.
Cell line models are more easily grown variants of their anatomical correspondents
that try to serve as an accurate model of the original tissue. Cell line cells are capable
of indefinite number of divisions making them in this sense superior to culturing
tissue samples. Especially in cancer research cell line models have been used largely.
The reason for this in addition to the challenges in retrieving the samples that cell
lines are rather easy to create from cancer cells since they already possess many
traits that force them to grow rapidly and refuse to die. Since cell line cells can
be rapidly grown and also can be stored at extreme temperatures without loss of
function after melting they provide an easy and cost-effective way to study different
tissue type characteristics and before all, different diseases. However, since the cell
line shows radically different behavior in proliferation than its original parent cells,
many other changes in the cells’ function may have occurred as well. It has to be
kept in mind that results produced in cell lines must always be critically reviewed
and validated with the original tissue. [14]
A myriad of various cancer cell line models exists, each with its characteristic
features. Only in prostate cancer over 200 cell lines and sub lines have been used
[20]. Only a handful of these, however, are in active widespread use: with this
restriction the number of prostate cancer specific cell lines reduces to little over 20
lines. One of the commonly used lines is called the LNCaP cell line. It has been
derived from prostate cancer metastasis in lymph node of a caucasian male patient.
LNCaP cell line exhibits androgen sensitive behavior which makes it an important
model for prostate cancer studies. [21]
2.3 Next Generation Sequencing
The Sanger sequencing method developed in 1977 by Frederick Sanger long remained
the most commonly used sequencing technology [22]. Enormous achievements like
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finishing the Human Genome Project and thus sequencing the first whole human
genome was completed using the Sanger sequencing. However, due to cost and
extensive amount of work and time required for the Sanger sequencing new methods
were urgently called for during the last decade [23]. As an answer to the need next
generation sequencing technologies (NGS) were developed. This naming convention
refers to the automated Sanger sequencing method as the ’first generation’ making
the modern methods the ’next generation’ of sequencing [24]. Here we discuss the
principles of these methods to comprehend the techniques that were used to generate
the datasets used in this thesis.
2.3.1 General Principles
The next generation sequencing techniques are a heterogeneous group of automated
sequencing methods capable of so called high-throughput data production. This
means they have the ability to produce very large amounts of sequenced nucleotide
fragments in relatively short time. Many different commercial manufacturers in-
cluding Illumina / Solexa, Roche / 454 and Helicos Biosciences to name a few,
have developed their own version of the sequencing technology. A modern high-
throughput sequencer is a table-top machine that can sequence the whole human
genome in a few days or even faster, producing tens of gigabytes of data. Most
common applications of NGS experiments are de novo genome assembly, identifica-
tion of Single Nucleotide Polymorphisms (SNPs) and other variability in genomic
structure, transcriptome profiling (RNA-seq), mapping transcription factor binding
cites (ChIP-seq) and profiling the structure of the chromatin for epigenetic markers
[25]
Next we consider the technology behind the common sequencing technologies.
The process of next generation sequencing can roughly be divided into steps of
template preparation, sequencing and imaging and data analysis. The actual im-
plementations of these steps, however, vary greatly between different commercial
manufacturers due to greatly differing technologies. These methodological differ-
ences result in variance between sequencing quality, output and price. [24]
The templates used in sequencing are recombinant DNA fragments that consist
of a known and unknown region. The known region is a specific sequence capable
of binding a primer sequence. The unknown part of the template, called also the
target sequence is the actual portion of interest, which will get sequenced in the
experiment. Typically, the sample DNA is fragmented to small pieces and attached
to known adaptors in the template preparation phase. These template sequences are
then attached to a surface immobilizing them and thus allowing massively parallel
sequencing of these templates. In many cases the templates are clonally amplified
since the majority of imaging technologies cannot detect signals using single template
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resolution. One approach in amplification is to use primer covered beads to which
a single template first binds. The template is replicated using PCR repeatedly
until finally the bead is covered with clones of the same template. Depending on the
technology, the beads are then either attached to a glass surface with chemical cross-
linking (Life / APG) or divided into specific wells (Roche / 454) to hold them in place
during the sequencing. Another approach is to use so called solid-phase amplification
utilized by Illumina/Solexa systems. Here a ’lawn’ of forward and reverse primers is
created on a solid surface and the templates are attached randomly to the surface.
The templates then bend and form primer-template pairs in a process called bridge-
amplification, where the initially one-stranded bridges are amplified using PCR to
eventually create clusters of similar templates on the surface [26]. In addition to
these clonal techniques, also single-molecule template utilizing technologies exist but
these are not considered here. [24]
In the sequencing and imaging phase the clonally amplified templates are sub-
jected to different methods where fluorescent nucleotides are allowed to bind the
templates which are then excited by laser and the emitted light is detected by a
imaging device. The method used by Illumina systems is cyclic reversible termi-
nation where nucleotides are attached to the template strands in cycles. The first
phase of the cycle is attachment of a single terminating nucleotide to each template
strand by DNA polymerase and the remaining free nucleotides are washed away.
The terminating property of the attached nucleotide is of crucial importance since
it prevents dephasing of the different template clusters.The attached terminating nu-
cleotides have also a phosphorylating group attached to then which is then excited
and the whole surface is imaged to determine the attached bases to each position.
The attached nucleotides are then cleaved for their terminating and phosphorylating
parts and these cleaved remnants are washed away before the beginning of the next
cycle. This cyclic process allows rapid and automated sequencing which is able to
produce enormous number of reads in relatively short time. [24]
Another approach used by Life / APG’s SOLiD platform is so called sequencing
by ligation where DNA ligase is used in cycles. The cycle starts by letting specific
fluorescent probes hybridize to the template strands. The probe is attached as
reverse complement to the template by a DNA ligase and after the unbound probes
have been washed away the platform is excited by laser and resulting emitting light
is detected to determine what kind of probe was attached to each position. The
SOLiD platform uses a two-base-encoding where each two-base unit’s sequence is
determined by a specific combination of consecutive probe binding. After excitement
parts of the probes are cleaved away and the cycle starts from the start. Due to
the special two-base encoding the first round of cycles cannot be used to determine
nucleotides at all positions of the template. Instead, a second round is followed
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started with a single nucleotide shift. The probe-attachment cycles are then run
again to the whole template’s length. The process is repeated altogether five times
resulting in five strands of linear color sequences. By combining the information of
these five rounds the actual sequence can now be determined.
A third method called pyrosequencing used by Roche / 454 incorporates single
nucleotide additions where DNA synthesis is halted not by terminating nucleotides
but by DNA polymerase manipulation. The polymerase is able to synthesize one
nucleotide to the template and then it pauses, after which the system measures light
emitted by a series of chemical reactions operating on released inorganic pyrophos-
phate. The light peaks can be detected in parallel by a imaging device and the cycle
can be re-initiated by activating the DNA polymerases to add the next nucleotide
to templates. The light peaks are stored and represented as a sequential collection
called a flowgram from which the correct nucleotide order can be read.
The last necessary step in the NGS sequencing experiment is genome alignment or
assembly. However, methods related to these topics are covered in more detail later
with other high-throughput data analysis steps. We continue by considering applica-
tions of the next generation sequencing. Various modifications of the basic method
exist: in addition to DNA sequencing a commonly used method to profile accurately
the transcriptome of the sample is to perform so called RNA-sequencing which is
in practice done by reverse transcription to cDNA, which is then sequenced. Many
other applications exist also, and in the following sections we introduce shortly two
applied sequencing technologies: DNase I sequencing and ChIP sequencing which
are constructed based on the basic DNA sequencing methodology but which use
specialized ways to obtain the sequenced material.
2.3.2 DNase I sequencing
DNase I sequencing (DNase-seq) is a relatively new technology published in 2010.
Although already a successive technology has emerged [28], DNase I sequencing
remains a well functional tool for high-resolution mapping of active elements in the
DNA. The method was developed to discover and identify active gene regulatory
elements in mammalian genomes by combining DNA ligating and NGS approach in
a novel way. [27]
The DNase I sequencing is based on DNase I enzyme which has the ability to splice
DNA at specific locations. As a specifically extracted and prepared DNA sample
is subjected to this enzyme it performs cuts at locations in the DNA that are not
blocked by bound proteins including histone complexes. This yields spliced DNA
fragments from all areas not blocked by DNA packing or organizing molecules, or by
dense heterochromatin. As the resulting fragments are sequenced and the output is
aligned to genome the ability of the experiment to show the areas of open chromatin
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is revealed. This information can be used in many applications especially related to
regulation of transcription in the cell. [27]
Previous low-throughput approaches utilized Southern blotting to deliver similar
information of DNase I hypersensitivity. The number of targeted sites was, however,
severely restricted due to lack of resources as the Southern blotting is not designed
for large scale experiments. The DNase I sequencing provides a high-resolution
alternative capable of genome-wide mapping of DNase I hypersensitivity. It is a
relatively straight forward protocol and can be applied to practically any sample
type. Challenges for the analysis of the technology’s outputs are that there are no
ways of determining which elements are interacting in the detected sites. In addition,
due to the methods rather young age the analysis methodology is not entirely well-
established as no clear method of choice exists. Finally, to use DNase I sequencing a
reference genome must exist and be available since the method produces reads only
from selected genomic regions which need to be aligned to the reference to produce
locations information of hypersensitive sites. [27]
2.3.3 ChIP sequencing
Chromatin ImmunoPrecipitation sequencing (ChIP-seq) is a combination of im-
munoprecipitation of specific elements of interest and subjecting the genomic se-
quences bound by these areas to next generation DNA sequencing. The ChIP se-
quencing method enables mapping the binding of various elements such as tran-
scription factors, modified histones and nucleosomes in a genome wide level. First
ChIP-seq experiments were published in 2007 and the technology has been in active
use by researchers from since. The ChIP sequencing method exceeds the preceding
microarray-based ChIP-chip technology in quality and quantity and is a powerful
tool for regulome profiling experiments. [29]
In ChIP sequencing experiment the states of DNA-bound molecules are frozen
with a fixation agent, usually formaldehyde. This treatment cross-links proteins to
DNA preventing them from detaching during the first phases of the experiment. Af-
ter protein cross-linking the DNA is spliced with a ligase producing a vast number
of DNA fragments, some of which bound by various proteins. Next, immunopre-
cipitation is performed using an antibody specific to the protein of interest. The
antibody treatment is used to extract the interesting proteins from the bulk of DNA
fragments. These fragments are isolated and afterwards the cross-linking is reversed.
The free DNA fragments are then sequenced yielding a collection of information of
the binding sequences of the studied proteins. [30]
Due to its high resolution, lower noise and greater coverage compared to the
preceding microarray technology the ChIP-seq has provided significantly better data
for mapping epigenetic markers and regulating factors on genome-wide level. The
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major challenges of ChIP sequencing lie in the analysis of the measurement data
- a subject considered in more detail in the following sections. The only practical
restrictions of the method are the existence and availability of a reference genome,
since the resulting reads need to be mapped against a reference to produce the
binding site information. Another restriction is the availability of efficient antibodies
for the protein of interest. Even though for the most common proteins strong and
selective antibodies exist, in studies targeting previously unstudied elements the
finding of a suitable antibody can be challenging. [29]
2.4 Microarrays
A microarray is a compact device capable of measuring features of a target molecule
on microscopic scale by using so called probes. The probes are short oligonucleotide
sequences that interact with corresponding sample, and quality and quantity of
the sample present can be measured based on a fluorescent property of the probes
which can be activated through stimulation with laser. DNA microarrays were
initially enabled by the development of nucleic polymer amplification methods such
as polymerase chain reaction (PCR) and the technology has since developed to
produce a wide range of different arrays for specific profiling purposes. [32]
Microarray technology was greatly responsible for the genomics data explosion
in the beginning of the last decade. The ability to map large proportions of the
genome, transcriptome and though applications also DNA-protein interactions pro-
duced a vast amounts of new information on different levels of cellular activity.
Also the integrative use of different ’omics’ data was emphasized when connections
between DNA-level modifications and for example, gene expression patterns were
noticed on genome-wide scale. The basic microarray technology was also found to
be very adaptive resulting in applications like copy number analysis and mapping
of epigenetic modifications. Although being currently a recessive technology due
to advancements in next generation sequencing, microarrays remain a cost-effective
and sufficient routine-like approach to many genetics studies. Typical workflows of
single-channel and two-channel microarray experiments are illustrated in Figure 2.5.
Single channel microarrays measure only one sample at a time using one dye while
the two-channel arrays are capable of measuring two samples at the same time using
two distinct dyes. [31; 32]
Although several commercial manufacturers make microarrays, here we concen-
trate on the structure and performance of Illumina Bead Arrays since they were
used to produce the microarray datasets used in this thesis. This type of microarray
consists of large number of beads placed in small wells usually on the surface of a
silicon/plastic slide. Each of the beads is covered with hundreds of thousands of
short identical oligonucleotide sequences known as probes. Each probe has a differ-
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Figure 2.5: Workflow a typical microarray experiment
ent set of oligonucleotides attached to it. In the experiment the beads are washed
with prepared sample solution where the DNA of interest has been fragmented to
small pieces. The fragments for which a reverse complementary probe exists hy-
bridize to their counterpart while the extra fragments are cleaned away from the
array. The hybridized probes are then excited with laser and specific fluorescent
groups in the probes activate, emitting light based on the degree of hybridization.
Since each bead contains a huge number of probes this allows dynamical measuring
of the DNA fragments: small amounts of certain fragment result in smaller emitted
light intensities while large amounts produce large intensities. The emitted light is
measured using an imaging device which interprets these to numerical data through
an automated software. This way, for example, in a gene expression measurement
the expression values are obtained indirectly through measured intensities emitted
by probe sets corresponding to a certain gene. [33; 14]
2.5 High-Throughput Data Analysis
The vast amount of data generated by NGS technologies is of course no use without
efficient analysis tools and pipelines. Analysis of NGS data presents itself as a
complex task that depends heavily on the aimed application of the experiment.
Here we will consider the analysis steps relevant to this thesis starting from NGS
data processing and peak detection and ending in microarray data analysis.
2.5.1 Next Generation Sequencing Data Analysis
Next generation sequencing data analysis is typically very application specific. Com-
mon steps for all experiments are usually pre-processing related tasks that often con-
sider issues like removing biases from the sequenced DNA fragments called reads.
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In addition to pre-processing many applications like RNA-sequencing require cal-
culation of read counts an their normalization often using modern model based
approaches to produce comparable robust gene expression data. However, since the
NGS applications utilized in this thesis do not require such normalization methods
we ignore them in our discussion and instead present some relevant features of the
NGS analyses that were used to produce datasets used in the thesis.
Preprocessing and alignment
The need for data preprocessing arises from errors and unwanted trends in the data
that could distort the results of the rest of the analysis. A bias in the measurement
data may be caused by various factors such as different measurement conditions,
varying amounts of reagents, careless performance of the experiments and biolog-
ical variance as the cells in different experiments are always at least in a slightly
different states. The modern sequencing machines typically contain a broad range
of preprocessing software that already performs many necessary adjustments to the
output data. Several types of bias may still remain in the data which need further
preprocessing steps. An error source called nucleotide per cycle bias pictures the
process where the distributions of sequenced nucleotides changes as a function of
the read so that the first nucleotides of the reads are most prominent to errors.
Another type of issue is the mappability bias which is caused by varying complex-
ity of different genomic regions. As the complexity of the genomic sequence affects
directly the probability of reads mapping to corresponding position, more common
sequences have a priori a higher probability of finding reads that map to their se-
quence. In some cases these bias types may seriously affect the following analyses if
left unattended. [25]
In addition to these general sources of error, method-specific biases exist also. For
instance, in the context of ChIP-seq data a quite recent finding states that ChIP-
peaks correlating with high gene expression may in fact contain largerly false signals:
the researchers had found that areas of high gene expression exhibit strong ChIP-seq
signals even though no protein of interest was actually present [34]. Another bias
type related to DNase-seq and especially its application to TF footprinting was re-
cently detected: it appears that the deterministic splicing of the DNA ligase enzyme
causes frequent gaps in the DNase-seq signal which can be easily misinterpreted by
TF footprint profiling software. This causes serious concerns for only DNase-seq
signal based methods of TF binding discovery and might also increase the false pos-
itive rates of other TF binding prediction programs making this bias type highly
relevant for our analysis [35]. However, no correction method exists for these bias
types. Still, it its necessary to acknowledge their existence so that not all results are
accepted directly but instead different error sources are carefully considered.
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Alignment to a reference genome is a basic step for most NGS data analyses.
Several suitable software exist for the task, most commonly known of these being
Bowtie and Maq. Bowtie is a fast and efficient aligner that uses the Burrows-Wheeler
transform for index construction allowing high performance in sequence querying.
Bowtie is capable of aligning both read-space and color space, although the more
advanced version Bowtie2 processes data only in read space [36]. Other tools such
as the splice junction discovery framework TopHat [37] have been developed on
top of bowtie. Maq is another widely used and capable sequence aligner designed
originally for Illumina / Solexa read space data but with additions capable of analysis
of color space data also [38]. The both aligners allow complex user preferences in,
for example, required mapping quality and allowed number of gaps, SNPs, insertions
and deletions.
Peak detection
In the scope of this thesis the peak detection is the most crucial part of NGS data
analysis. Peak detection is a typical challenge with sequencing types like ChIP-seq
and DNase-seq since these datatypes typically exhibit condensed groups of reads
in dispersed locations around the genome. To find and distinguish these regions
effectively, automated methods are necessary and indeed many such methods have
been developed. Here we will quickly discuss two peak detection methods: HOMER
and MACS.
MACS or Model-based Analysis of ChIP-Seq data was designed to analyse the
output of of short read sequencers. MACS uses a Poisson distribution model to
distinguish between signal and background. Using the concept of background is
of crucial importance since in every experiment due to errors some reads end up
aligning in unexpected positions. Such cases need to be recognized which is usually
performed by calculating a background density, often as a long distance average.
MACS also takes into account the fact that sequencing of the previously protein
bound DNA fragments results in a bi-modal peak. These two overlapping peaks form
a characteristic pattern for protein binding and can at best be used to distinguish
the binding sequence even in single nucleotide resolution. Generally, MACS has
been used widely and is still a very common method in ChIP-seq peak detection.
[39]
HOMER (Hypergeometric Optimization of Motif EnRichment) is a motif dis-
covery and next generation sequencing analysis framework first published in 2010.
HOMER possesses a great variety of functions and it’s peak detection algorithm
is capable of detecting ChIP-seq and DNase-seq peaks, histone enrichment regions
and detect transcripts from GRO-seq data. The algorithm for ChIP-seq and DNase-
seq works by first creating ’tags’ at high read count locations. The tags are then
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attempted to be shifted center positions of the presumably detected edges of the bi-
modal peak. By combining density information from different tags the final peaks
are formed by combining or masking sequences between nearby tags.[40]
2.5.2 Microarray Data Analysis
Microarray data analysis is a quite well established process due to the crucial role
of microarrays in the data-driven development of genomics during the last decade.
The fixed parts of every microarray data analysis workflow are preprocessing and
normalization, often also followed by differential expression analysis. We now review
these concepts in more detail, putting emphasis to those methods relevant to this
thesis
Pre-processing
The microarray experiment is naturally prone to all the usual errors of a laboratory
experiment. These experiment-related biases like sample treatment and preparation
are always difficult in the sense that often not much can be done to correct these early
phase errors. Some more minor biases like small differences in sample treatments can
usually be handled, however, and they form an important part of pre-processing. In
addition, technology related biases are also common: microarray experiment results
need to be adjusted according to probe affinities since different probes have different
tendency to bind their complementary sequence. In addition, the used fluorescent
dyes may induce biases to the data and of course the array itself needs to be carefully
constructed and fully functional.
Background correction is a basic preprocessing step where the intensity estimate
of the background caused by unwashed fluorescent dyes is subtracted from the probe
intensities. Also in the case of two-channel microarrays intensities of the samples
measured on one chip are often represented as a log2-ratio to minimize certain dye-
related biases. To increase this further, when measuring biological replicates the
samples are often dye-swapped, that is, the dyes used to detect treated sample
intensities and control sample intensities are switched in turns. While nowadays
also the manufacturers often provide methods like binding affinity profiles for pre-
processing of technical biases, despite all efforts many of the mentioned error sources
may remain in the data even after pre-processing steps.
Normalization
In addition to pre-processing the data usually also normalization is warranted. In
fact, normalization is often considered an inseparable continuum to pre-processing
and helps to reduce the effect of still untreated biases even further. Normalization
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methods are applied to the data to make it comparable within-chip and between
different chips. Many methods of normalization have been developed, especially for
the Affymetrix arrays due to their common use. A common normalization procedure
for these arrays is the so called Robust Multiarray Average procedure where several
consecutive steps skew the distributions of all samples so that the resulting inten-
sity values are proportionate and thus comparable. However, since the microarray
data used in this thesis is generated using another technology, we present here a
normalization method applicable to our data: quantile normalization.
Quantile normalization is a widely used method where the distributions of ex-
pression values from different measurements are made comparable by forcing similar
distributions for the values of different samples. The process is illustrated in Figure
2.6. The similar distributions are achieved by sorting the values of each sample
and calculating then row averages of the resulting matrix. Here the row average
means the average expression of a single gene across all measured samples. The row
averages are then returned in places of the original values in order determined by
the original value sorting. Since all samples have now the same expression values in
various permutations the distributions of the samples are now equal. This is essen-
tial before between-sample comparisons can be performed to avoid skewed results.
In addition, also within-sample normalization schemes are often applied to the data,
for example to make the samples genes comparable with one another. Own methods
such as Lowess normalization have been developed for this purpose. However, since
in this work we had the advantage to utilize readily pre-processed data we ignore
this part of normalization in this discussion.
Figure 2.6: The principle of quantile normalization
Differential Expression
Differential expression means the detection of significant difference between expres-
sion levels of a target of interest, typically a gene, in two samples. A typical exper-
imental setup compares a sample treated with specific reagent to a control sample
with no corresponding treatment. To define the ’significant’ difference usually three
different conditions must be met. First, the difference in expression must be clear
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- usually at least two-fold difference in expression is required. Secondly, the result
must be also statistically significant based on some test over treated samples against
control samples. A paired t-test is often applied to determine this significance based
on differences and similarities in treated sample replicates and control sample repli-
cates. This sets requirements to the whore experimental setting since with a small
number of biological replicates a reliable statistical testing cannot be performed and
this aspect of differential expression is lost. A third requirement for true differen-
tial expression is some underlying biological function which explains the difference.
This is of course difficult to determine and is often the final result of the whole
experiment.
2.6 Different Ways to Express Transcription Factor Binding
For computational methods transcription factor binding must be representable in
an efficiently usable format. Due to the ambiguous nature of TF binding the format
must also allow flexibility. In this section a historical method and a state-of-the-art
method of expressing TF binding information are reviewed.
2.6.1 Consensus Sequences
Many applications in bioinformatics and biology require the representation of short
patterns of nucleotide sequences. Traditionally the binding domains of a TF were
expressed as a consensus sequence. The consensus sequence is a stream of nu-
cleotide characters representing a certain domain in the DNA. For instance, a con-
sensus sequence of TAAGAC would mean that the TF in question binds only to these
specific nucleotides in the DNA. The consensus sequences can be also more am-
biguous by replacing some of the bases with characters that signify a choice among
several nucleotides. For example the consensus sequence TANGRS would be inter-
preted according to the IUPAC nomenclature for incompletely specified bases as
TA[A,T,C,G]G[G,A][G,C] where the brackets indicate choice of one nucleotide in-
side them [41]. This way a set of possible TF binding sites could be easily represented
as one consensus sequence. [7]
The usage of consensus sequences suffers from some issues, however. As the TF
does not bind only one specific sequence but rather a wider range of sequences the
ambiguity of the consensus sequence grows rapidly. For instance, if a TF were to
bind often AACAAT but also occasionally TACAAT and AACAAA the consensus sequence
would have to be WACAAW where W represents a choice between A and T. However,
this notation would also allow sequence TACAAA which is not among the binding
sites of the TF. Thus, the ambiguous representation results into sequences that are
unwanted and is therefore a tradeoff between mismatches and precision. Deciding a
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consensus sequence is therefore somewhat arbitrary and in general does not represent
all the binding domains exactly but only closely enough. [7]
In addition to the tradeoff between precision and errors in a consensus sequence,
many TFs typically bind their wide range of different response elements in such a
way that each base in the domain has an individual affinity to bind. When in some
locations of the domain the base of the response element needs to be always fixed for
binding to occur, in other sites the base may vary without preventing the binding
but with a contribution to the overall binding affinity. Consensus sequences are,
however, unable to take into account this kind of variation in binding affinity when
at each location the base is interpreted to be either a match or mismatch, leaving
the gray area of partial binding unattended. Due to these limitations of consensus
sequences other methods have been developed to represent binding motifs of TFs.
2.6.2 Binding Motifs as Position Weight Matrices
A generally appreciated and more robust solution to representing binding domains
of TFs is the position weight matrix (PWM), also known as position specific weight
matrix (PSWM). A PWM is derived from a position frequency matrix (PFM) where
a frequency of nucleotide occurrences is calculated for each nucleotide at each posi-
tion of the motif. Thus, the PFM forms a 4×N matrix where N is the length of the
motif and each row corresponds to a different nucleotide. From a PFM the position
weight matrix is calculated by diving each frequency count at a specific location by
the sum of all frequencies at that location, normalizing the frequencies into weights
from interval [0, 1]. Mathematically this can be stated as
PWM i,j =
pij
pi
, (2.1)
where pi is the sum of all nucleotide frequencies at position i and pij is the frequency
of given nucleotide j at position i. This gives an effortless way to represent a motif
of N nucleotides while allowing individually arbitrarily varying nucleotides in the
sequence.
A position weight matrix is typically used to represent the binding motif of a TF.
Since the binding motifs are often ambiguous in the sense that nucleotides at some
positions in the motif may vary between any of two, three or even four nucleotides,
it is beneficial to use PWMs to show the motif. Because the continuous nature of
PWMs they are superior to the consensus sequences in representing binding: be-
cause the ambiguity of bases is not static but instead based on a probability arising
from the underlying PFM, much higher resolutions in binding affinities are achieved.
Using a position weight matrix each subsequence in the genome can be scored for
each TFs binding at single nucleotide resolution. The scoring is performed by select-
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ing a value from the PWM corresponding to the nucleotide at that location. The
values for the whole sequence are then multiplied together to form one figure that
represents the binding affinity between used binding motif and genomic sequence.
Due to the definition of PWM values the overall score belongs to interval [0, 1] where
1 represents a perfect match and 0 the worst possible match. The scoring is given
as mathematical formulation in Equation 2.2 as
PWMS =
N∏
j=1
PWM i,j
bi
, (2.2)
where PWM is the position weight matrix of a TF, N is the length of the matrix,
j is the location in the sequence, i is the nucleotide at location j that corresponds
to a row in PWM and PWMS is the overall score the sequence receives. Also a
normalization term bi is included here which represents the probability of facing this
nucleotide in the sequence. Nucleotide compositions are highly organism specific as
the so called GC-content, that is, the amount of G and C bases compared to A and
T, varies greatly from one species to another. This has to be taken into account
in the scanning by using the presented normalization factor. As can bee seen from
the equation the PWMS calculation assumes binding independency of consecutive
nucleotides. Attempts to correct the model to take dependence into account have
been made but they are not considered in this thesis. [42]
Also another formulation of the PWM score calculation is presented in [42]. This
version calculates the sum of log-likelihoods of all locations in the sequence:
PWMij = log2
(
pij
pi
)
PWMSij =
N∑
j=1
PWM i,j
bi
, (2.3)
where variables are as declared in the previous equation. As the sum of log-
likelihoods corresponds to a logarithm of product of likelihoods the two definitions
are essentially the same with the exception of the latter score is log2 transformed
while the former is not. However, since the former definition scales the results prac-
tically to interval [0, 1] and highlights the differences between scores more due to
use of multiplication instead of sum, the former representation is chosen to be used
in the calculations.
2.7 Previous Approaches to Transcription Factor Binding Pre-
diction
The prediction of transcription factor binding is not a new challenge and attempts
to overcome it have been made several times. The different methods can be roughly
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divided into two classes. First class of methods considers signatures in the DNase
data that indicate TF binding. A binding signature is formed of a area of elevated
DNase signal which suddenly drops for a short period suggesting TF binding, and
then returns back to its elevated state. As such a signal could indicate binding of
any factor, nucleotide sequence of the signal area is afterwards scanned for binding
motifs of different TFs. The initial method proposed a greedy algorithm for TF
binding signature finding, and was soon followed by other implementations utilizing
Bayesian network, hidden Markov model, and Bayesian probability based model
which derives its prior probabilities from DNase signatures. [43]
A challenge for these methods is the ambiguity of the TF binding signature: the
methods do not distinguish between DNase signals of different TFs. An alternative
approach considers this issue by first scanning the genome for putative TF specific
binding sites and then introducing the DNase information of the surroundings of
these so called candidate binding sites to locate the most probable actual binding
sites of the TF. The first such method called Centipede implements a Bayesian mix-
ture model that is adjusted to optimal performance using unsupervised learning and
expectation maximization algorithm. Centipede combines data of position weight
matrix scanning, sequence conservation, gene proximity information and DNase I
hypersensitivity signals to form a comprehensive prediction of putative sites of TF
binding to DNA. The developed model was shown to produce admirable results and
the authors expected to see it applied to genome-wide prediction studies. [44]
The apparent successor to Centipede published in 2013 is a logistic regression
based method called Millipede. The naming convention is due to the reduced num-
ber of inputs required by the method even though achieving similar results. The
Millipede logistic regression model takes into account the DNase I hypersensitivity
information +/- 100bp around the candidate binding site and merges this with pre-
dicted binding affinity. The approach extracts the DNase signal and summarizes it
to bins in various ways which are then given as input to the method. The Millipede
model is formulated as
log
(
pi
1− pi
)
= β0 +
B∑
b=1
βb ∗Db,i + βPWM ∗ PWMi + βcons ∗ CONSi, (2.4)
where β0 is the intercept, B is the number of DNase signal bins, Db,i is the sum of
DNase signal in bin b at site i, PWM is the score of position weight matrix scan-
ning ath location i (considered in detail later) and CONSi is the optional sequence
conservation score for sequence starting from position i.
The Millipede model was shown to produce as good results as the some orders
of magnitude more complex Centipede approach. In addition, with yeast data the
Millipede exceeded the performance of the untuned Centipede model showing much
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better results making it a method of choice for TF binding prediction at the moment.
Thus, Millipede was used in our applied approach as a filtering and comparative tool
to evaluate our own findings with a reliable method. [43]
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3. MATERIALS AND METHODS
3.1 Datasets
The methods in this thesis use various datasets. All of these have been obtained
from freely available sources produced by previously published works. Here a short
summary is given of the different data types used in the research and their sources.
3.1.1 DNase I -sequencing Data
The DNase I sequencing data used in the predictions was generated by [45]. The
study concentrates to show the connection between DNase I hypersensitive sites
and androgen receptor and estrogen receptor binding using hormonal stimulation
in LNCaP prostate cancer cell line and MCF-7 breast cancer cell line, respectively.
We obtained the DNase I data from sequencing experiment in synthetic androgen
(DHT) treated LNCaP cells. According to the published data the cells were treated
with DHT for 4 hours prior to the experiment and sequenced with Illumina Genome
Analyzer sequencer using manufacturer’s instructions in sample preparation[46].
Since the DNase I sequencing data is the most important prediction control ele-
ment in our binding prediction analysis we used also another data set produced by
the ENCODE project. This data was made available by the ENCODE consortium
as BED files containing peaks of DNase I active areas. The peaks were calculated
by first locating so called DNase hotspots, that is, broad areas of DNase activity
and these were further subjected to peak detection algorithm which located local
maxima of activity using a fixed length 150 base pair window sliding through the
hotspot with 20 base pair steps. These local maxima were then reported in the
available BED file as 150 base pair intervals of DNase I activity peaks. The file used
in our experiment consists of pooled peaks from all DHT processed LNCaP cell
experiments performed withing the ENCODE project. In the case of overlapping
peaks pooling was conducted by favoring the peak with higher Z-score calculated
based on DNase signal of the non-overlapping parts of the peaks.
3.1.2 ChIP-sequencing Data
For different individual ChIP-seq experiments were used in validations of generated
predictions. The ChIP-seq datasets differ slightly from their sample treatments
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which enables wider discussion when assessing validation results. The sets are re-
ferred to as Sahu, Yu, Massie and Urbanucci. All the sets are generated from LNCaP
cells treated with synthetic androgen R1881 before the experiment.
The Sahu ChIP-seq data originates from a recent study AR and GR binding was
examined in LNCaP and VCaP cells. The cells in the used sample were treated with
100nM DHT for 4 hours prior to experiment. The resulting sample was sequenced
using Illumina Genome Analyzer following manufacturer’s protocols. The resulting
reads were mapped to genome using Bowtie and scanned for peaks with MACS
software. Overlapping peaks from biological replicates were selected with 2% FDR
cutoff value. [47]
The Yu ChIP-seq data was originally used in AR subnetwork and TMPRSS2-
ERG gene fusion profiling. A dataset with 16 hour R1881 treatment was used. The
sample was subjected to 48 hour androgen deprivation before the R1881 treatment
The resulting sample was sequenced using Illumina Genome Analyzer standard man-
ufacturer procedure. Reads were aligned using Illumina’s ELAND software. Peaks
were originally detected using an unpublished Hidden Markov Model-based software
so a new peak calling had been performed by the Computational Biology group at
Tampere University using MACS peak detection. [48]
The Urbanucci dataset was generated originally to study AR overexpression and
its effect on AR-chromatin interaction. One of the measured samples was used in
this work. The selected sample was treated with 1nM R1881 for 2 hours and before
that subjected to androgen deprivation for 4 days. The used cell line was a special
variant of the LNCaP cell line named ARhi, exhibiting native overexpression of AR.
Illumina Genome Analyzer was used to sequence the samples, resulting reads were
aligned using Bowtie and peak calling was performed with MACS software. [49]
The Massie dataset was generated to support the mapping AR downstream tar-
gets. The sample used in this study was treated with 1nM R1881 for 4 hours prior
to the measurement. The sample was sequenced using Illumina Genome Analyzer
and aligned to reference genome using MAQ aligner. Peak calling was originally
performed by MACS and ChIPSeqMini choosing but was repeated by our Compu-
tational Biology group using only MACS for comparability. [13].
3.1.3 Gene Expression Data
Gene expression microarray data used in the work was generated with Illumina
HumanWG v2 BeadArrays. The two replicate sections of the arrays were treated as
technical replicates to minimize small systematic errors noticed to be produced by
the method. Raw level bead data was analysed with the manufacturers beadarray
software and removing spatial artefacts using an automated method (BASH). The
prepared dataset was published in Gene Expression Omnibus (GEO) from where it
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was also obtained for this thesis. [50]
3.2 Computational Methods
To make use of the various data sources listed previously several computational
methods were applied and constructed to create a framework able to create tran-
scription factor binding predictions and combine these into a genome wide network.
This chapter presents the computational methods used in this thesis.
3.2.1 Binding Motif Databases
Several online databases curate and distribute information of transcription factor
binding motifs. While some databases charge their usage in this thesis only freely
available databases have bee utilized.
JASPAR
JASPAR is an open-access online database of eukaryote transcription factor binding
motifs originally published in 2003. JASPAR presents a curated high-quality collec-
tion of motifs represented as location based score matrices. In addition to different
web based search tools accessible at the database website JASPAR also offers the
possibility of database and plain data download. Original JASPAR collection con-
tained 111 scored DNA binding motifs. Later additions have largely increased the
size of the database and the fifth, that is, the most current version published very
recently in 2014 contains 457 curated motifs [51]. While these have mainly been
generated using SELEX experiments also more modern techniques like Chromatin
Immunoprecipitation Sequencing have been exploited in determining the motifs. [52]
JASPAR declares to distinguish itself from other similar data sources due to three
factors. First the open access is considered a major advantage of the database and
it also has a built-in API for easy usage. Most importantly, however, JASPAR’s set
of binding motifs is non-redundant trying to consist of only the best binding motifs
available for each transcription factor. Although this is an issue when considering
the modern measurement technologies which data allow the generation of different
species specific binding motifs for same TFs, the non-redundancy ensures a clarity
and reliability of the presented motifs. [52; 51]
UniPROBE
The universal PBM resource for oligonucleotide binding evaluation or UniPROBE
is an open access database of DNA binding domains of transcription factors. Unlike
the factors stored in the most widely known databases JASPAR and TRANSFAC
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that have been produced with multiple measurement types, the TF binding motif
data in UniPROBE has been generated using universal protein binding microarray
(PBM) technology. The PBM technology consists of a microarray of short 10-
mer nucleotide probes that are designed to resemble all possible permutations of
nucleotides. The probes are double stranded and TFs of specific type are allowed to
bind the sequences. These bindings can be detected and thus the bound sequences
can be deduced. This measurement gives a high-throughput way to map all possible
binding motifs of short binding motif TFs. [53]
The original UniPROBE database contained PBM derived non-redundant binding
motifs from 175 TFs from various species. The database has been updated with
several of publications and at the moment contains 11 different publications. The
collection currently consists of 406 TF binding motifs from several species including
human. [54; 55]
TRANSFAC
The TRANSFAC database initially published in 2010 provides a commercial op-
tion to the open-access TF databases [56]. TRANSFAC is a resource of eukaryote
TFs, their binding sites and binding motifs represented as position weight matrices.
The database is continuously curated and its features are frequently updated. A
restricted and outdated free version of TRANSFAC from year 2005 is also provided
[57]. The public database is, however, severely inferior to the commercial version:
the free version contains 398 PWMs while the commercial one claims to contain
even 5551 PWMs. The commercial database also promises advanced data search
and analysis tools and a possibility to data download [58].
3.2.2 PWM Scanning
Position weight matrix scanning was performed using a modified version of PSWM
scanning software by a Tampere University Computational Biology group collabora-
tor Harri Lähdesmäki. The original code written in MATLAB implements a simple
DNA sequence scanning with a given 4×N PWM using the product based calcula-
tion method presented in equation 2.2. The algorithm also calculates a background
score based on nucleotide frequency in the region to-be-scanned, thus normalizing
the resulting scores in respect of the bias caused by uneven probability of differ-
ent nucleotide occurrence. In addition, to extract significant scores the algorithm
performs a background scan using a 100 fold longer randomized sequence than the
actual sequence-to-be-scanned. The scores from the inspected sequence are then
thresholded so that all DNA locations with a score equal or above a fixed thresh-
old highest scores from the background scan were accepted as so called candidate
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binding sites.
The performance of the scanning was first validated by scanning the 1000bp
upstream sequence of gene ELK4. Confirmed binding sites of AR had previously
been reported in the promoter proximal region of ELK4 at positions −167/ − 153
and at −481/− 467 counting from the transcription start site of the gene [59]. The
peaks of the scanning were plotted to Figure 3.1. As can be seen the implemented
PWM scanning finds relatively high scores very accurately at these locations. Even
though the left peak seems quite modest in size it was separately confirmed that
all the visible peaks in the plot are at least one order of magnitude larger than the
remaining peaks. This finding shows arguably that PWM scanning can be used as an
effective prediction tool for finding TF binding sites. It is worth noticing, however,
that in addition to the two confirmed peaks the prediction finds a few other peaks
as well. These can well be unannotated true binding sites of the AR but also just
random bits of sequence happening to have a permutation that resembles the AR
binding motif. Indeed, the distinction between true binding sites and false positives
is one of the hardest tasks in PWM based TF binding prediction.
Figure 3.1: PWM scan of ELK4 1000kb upstream sequence
The suggested threshold of 0.1% was selected also to our analysis after examining
AR binding upstream of gene TMPRSS2 transcription start site. The Figure 3.2
shows a log2 transformed histogram of the PWM scan scores bor randomized back-
ground scan (dark blue) and scan of a 100kb upstream sequence from TMPRSS2
gene (cyan). The light blue effect shows the areas of the histogram where the two
plots overlap. As the PWM scan results were in range [0, 1], after the log-transform
the scale becomes (−∞, 0] where larger value is better scan result. As can be seen
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from the figure, even though the TMPRSS2 upstream sequence scan produces 100-
fold less scores than the broader background sequence scan, the right tail of the
sequence scan seems to be thicker than the tail of the background scan. This gives
more confidence in the AR PWM motif we are using since it seems that scanning
actual biological sequence with the motif produces more high score hits than scan-
ning completely random sequence. This corresponds to the biology of the scanned
sequence: the TMPRSS2 upstream sequence is expected to contain several binding
sites for AR and at least according to these histograms it seems we are able to locate
some of these sites.
The significance threshold filtering was modified to express the output significance
as pvalue based on location in the background threshold, thus calculating for each
gene i at location j
pvali,j =
#(PWMSi,j > bg)
#bg
, (3.1)
where PSWMi is the PWM scan score for the ith gene at some location j, bg is
the list of background scan scores and # signifies the number of elements. Now the
previously formed threshold of rejecting 0.999% least significant genes turns into
pvalue threshold pval = 0.001.
The filtering threshold for significant hit in this example becomes in log2 scale
−24.1. This seems to be a rather strict criterion judged from the figure but it was
selected since it certainly rejects the bulk of low scores and should severely restrict
the number of false positives. Even though different PWMs have varying lengths the
background scanning is assumed to ensure that the threshold calculation is scalable
to other transcription factors also and thus acts as a reliable criterion to separate
significant scores from non-significant ones.
3.2.3 DNase Peak Detection
Peak detection of the Housheng et al. dataset had been performed by the Tampere
University Computational Biology group researchers previously. The method used
was HOMER peak detection. The peak detection for ChIP/DNase-seq peaks had
been used for our DNase I sequencing dataset with peak size estimation 185bp. From
the detection results it can be seen that the estimation is only loosely followed since
the resulting observed peak size on average is 355bp.
3.2.4 Prediction Efficiency Validation
Predictions generated with different methods were validated by examining the pre-
dictions of AR binding using the ChIP-seq dataset as ground truth. For simplicity,
all comparisons were performed in chromosome 20 and assumed robust enough to
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be applicable to whole genome level if necessary. ROC curves were used to rep-
resent effect of thresholding PWM scores. Here we hypothesized that filtering the
low PWM scores would reduce the number of false positives as gradually only the
sites with strongest affinity remain. For the ROC curves the validation ChIP-seq
peak set was prepared in similar manner as described in the Millipede publication:
Positive TF binding set was defined to be the overlapping hits of ChIP-peaks and
predictions while the negative TF binding set was defined to be the set of candi-
date binding sites not falling into ChIP-peaks. In the context of ROC curves this
construction forgets the existence of possible ChIP-seq peaks that are not detected
by predictions and shows only the changing performance in finding the detectable
peaks when the filtering criterion of PWM score is changed. To consider also the
fraction of missed ChIP-seq peaks this is reported separately with every approach
along with discussing the number of true positives and false positives in the case of
unfiltered PWM scores.
3.2.5 Gene Expression Enriched Network
To form most accurate picture of which regulation connections are present in the
cells, gene expression data from LNCaP cells was applied to the constructed network.
This was done in two separate phases: first, static state gene expression data with no
androgen stimulation was used to filter out all regulation connections between very
low expression genes from the network. This forms a greatly reduced new network
which pictures more accurately the regulation present in the cell in steady state.
In addition, as a second phase, DHT stimulated gene expression data was used to
uncover the downstream regulation patterns of AR in high detail. The differentially
expressed genes at time point 4 hours were calculated from the time course data
and these were used to combine the findings of predictions and actual measured
differential expression, and as a proof a small AR downstream network was profiled.
3.2.6 Predicted Network Inference
The network of regulation connections was constructed from the predictions by
considering the predictions 250kb upstream of gene TSS possible regulators of the
gene. Locations of these predictions along with the TF and target gene were saved
to a file in BED format. For visualization this format was still flattened in boolean
yes/no fashion to a list of connections between all TFs and genes. This list was then
used to visualize the predicted networks using program Cytoscape, a commonly used
network visualization tool.
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4. RESULTS AND DISCUSSION
4.1 Assessing the ChIP-seq Validation Reliability
To be able to validate the results of different prediction approaches the quality of the
ChIP-seq data used is of vital importance. To ensure the robustness of performed
validations four different ChIP-seq datasets were used independently to validate all
PWM scanning results. A summary of ChIP-seq peaks inferred from these datasets
is presented in Table 4.1. As can be seen the sets contain quite different amounts of
detected peaks. The sets had, however, received slightly differing treatments prior
to the experiments which without doubt explains greatly this variance. Another
explanation is the used peak calling. Even though the peaks of all datasets were
detected with same software it is probable that different parameter settings resulting
in different numbers of peaks.
To validate the datasets in the sense of PWM scanning the sequences corre-
sponding to reported peaks in chromosome 20 were extracted from the UCSC hu-
man genome version hg19. These sequences were subjected to PWM scan using
the binding motif of AR and maximum scores were calculated from each segment.
Assuming the filtering criterion calculated when examining AR peaks in upstream
sequence of TMRPSS2 stays relatively same, the number of maxima larger than
the threshold pval = 0.001 corresponding to PWM scan score 5.7403e − 08 were
calculated. These sums were collected to Table 4.1.
If a ChIP-seq peak covers such a genomic sequence where all PWM scores are
below the set threshold, this peak is impossible to detect for any PWM scan based
method. As can be seen from the table the numbers of detectable peaks against
all reported peaks differs quite largely in the case of stricter filtering with pval =
0.001. The Massie and Urbanucci sets seem to match quite well areas of detectable
peak scores. However, the large number of peaks in the Yu set on areas where
Table 4.1: A summary of the ChIP-seq datasets used in validations
Sahu Urbanucci Massie Yu
Total number of peaks 16971 2399 11785 35363
Peaks in chr20 449 57 233 758
Detectable peaks, pval=0.001 278 39 181 489
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only relatively low PWM scan scores were observed raises doubts concerning the
experiments success: approximately 250 peaks were located on areas of low PWM
scores which is a significant percentage of all the Yu peaks. While difficult to prove,
this the possibility of bad quality dataset naturally exists. There can easily be issues
in the ChIP-seq sample preparation, measurement, read processing or peak detection
along the way and it is practically impossible to tell whether or not something
unwanted has happened to the data since it is generated and analysed by us. Thus,
using another ChIP-seq dataset for validation, or perhaps a combination of sets
would result in a valid.
Another likely explanation is that the unobserved peaks are caused by indirect
binding through protein-protein interactions. The same holds true for the other
datasets as well This indirect binding could well be observed in the ChIP-seq ex-
periment when the whole complex is cross-linked to DNA and gets selected by anti-
bodies due to AR being one of its subunits. Indirect binding is, however, difficult to
prove and since the used methods are require DNA binding for detection the indirect
binding and its effects are unfortunately outside reach of this study.
4.2 PWM Scanning
PWM scanning was performed using each of the 672 TF motifs extracted from
the publicly available JASPAR and UNIPROBE. The sequences 250kb upstream of
every gene annotated in UCSC genome version hg19 were first extracted from the
hg19 primary assembly to a FASTA file based on annotated gene coordinates. Even
though the initially scheme when planning the experiments was to scan all of this
sequences with all motifs, this proved quickly too time demanding for the scope of
this work. Especially the 100-fold background scan phase increased the predicted
runtime of the PWM scan to several months resulting into rejecting this original
plan. Instead, the information from DNase sequencing was used first to filter out
areas of closed chromatin in order to reduce the number of sequence-to-be-scanned.
4.2.1 Naive DNase Filtering
The first attempt to utilize DNase signals calculated from the DNase I sequencing
experiment was performed using the simplest possible approach. The sequenced
reads were transformed into a bedgraph file with reverse and forward strand reads
counts summed together to form a DNase-seq signal. The approach then applied a
fixed threshold to the signals stating that areas with signal higher than the threshold
are the areas of interest with accessible chromatin. A histogram of the DNase-seq
signals in chromosome 20 was used as a rough tool in determining a fitting threshold.
Judged from the histogram it became clear the bulk of the DNase-seq signal values
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Table 4.2: Naive DNase-seq signal based PWM scan
Sahu Urbanucci Massie Yu
Overlaps 38 8 18 31
Percentage of detectable 13.7 20.5 9.9 6.3
True Positives 84 25 41 66
False Positives 190 249 233 208
is near zero or zero signifying the majority of the DNA is inaccessible to TFs. After
this examination the threshold was set so that signals with values larger than 95%
of all signals were judged significant. Calculated as a signal threshold and rounded
to integer, as the signals were integers also, this gave a threshold value of 4. As seen
in the histogram the threshold seems to quite effectively filter out the bulk of low
signals while the interesting high signals remain.
This scan yielded in total 3, 448, 766 binding sites for all TFs which corresponds
to approximately 5, 100 binding sites per TF on average genome-wide. When con-
sidering the scanned sequence length was still roughly 41,000,000bp for each of the
PWMss this number seemed surprisingly small. Indeed, when examining the bind-
ing predictions of AR in chromosome 20 only 277 predicted binding sites were found
in the whole chromosome.
Results of the scan validations with all ChIP-seq datasets is presented in Table 4.2
In the table the first row shows the number of explained ChIP-seq peaks, the second
tells the percentage of explained peaks among all detectable peaks, the third shows
number of predictions overlapping ChIP-peaks and the fourth number of predictions
missing all ChIP-peaks. These validations were implemented by calculating overlaps
between predictions and ChIP-seq peaks allowing partial overlaps but no tolerance.
As can be seen from the table the overlaps between predictions and validation peaks
are scarce. It seems that every one of the validation sets are explained rather poorly
by the predictions: only few predictions overlap with ChIP-peaks while still majority
of the predicted binding sites are false positives.
Also a ROC curves were plotted to determine whether filtering of the predictions
according to PWM score results in fewer false positives and better precision. The
ROCs are shown in Figure 4.1. As can be seen the thresholding with PWM scores
does not seem to result in better performance in this case. Instead the few true
positives predicted seem to get filtered out even faster than the false positives,
suggesting that at least after some threshold the PWM score might not be in crucial
role in determining the true binding sites.
Two different explanations were devised for this behavior. Either the DNase-seq
signals used do not overlap the ChIP-seq validation peaks in many positions at all,
or the method the DNase information is used is not optimal. The overlaps between
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Table 4.3: Overlaps between DNase-seq signals and ChIP-seq peaks
Sahu Urbanucci Massie Yu
Overlapped peaks 388 52 197 592
Percentage covered with DNase 86.1 91.2 84.6 78.1
the Housheng Dnase-seq dataset and ChIP-seq peaks was inspected and it was noted
that while not all peaks were covered by DNase signal the majority of them showed
at least partial DNase-seq signal overlaps. The overlap percentages are presented
in the Table 4.3. The overlap percentages are quite high indicating that almost
all peaks are throughly covered with DNase signal. This suggests that majority of
the peaks be detectable also according to DNase-seq signals. Thus, the issue with
prediction precision seems to lie elsewhere that in insufficient DNase-seq coverage.
The second apparent error source is thus the used method itself. Since very low
numbers of peaks were detected by predictions - for example with the Sahu data
only 8.5% of the ChIP-seq peaks - while generously over half of the peaks should
be detectable, it seems that the detection method indeed is too inaccurate. This
was looked in more detail by examining the DNase-seq data using the Integrative
Figure 4.1: ROC curve of naive DNase-seq based PWM scan
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Genomics Viewer (IGV) software and showing the predicted binding sites and the
DNase-seq signals resulting from the thresholding. We noticed that the DNase-seq
sequencing depth and the nature of the data both contribute to the fact that the
thresholded DNase-seq signal areas observed were short and fragmented. The limited
sequencing depth and on the other hand the fact that there is a gap in the DNase-seq
signal at protein binding sites resulted in frequent fragmentation of the DNase-seq
signals since the fixed threshold allowed no flexibility and an area considered open
chromatin was cut every time the signal descended below 5. The short fragmented
scan sequences allowed unrealistically short areas of DNA to be scanned and large
amounts of candidate binding sites were lost. In addition, the thresholding process
also eliminated some of the most promising binding sites since in many cases at
sites clearly resembling protein-bound DNase-seq signal when looked by plain eye
via IGV, had so low signal gap that the sequence was split in two just at this critical
location. Thus, this first attempt was named naive DNase filtering due to its simple
fixed threshold based usage of DNase-seq information and as a following step a more
refined approach to utilize the DNase-seq information was devised.
4.2.2 DNase Peak Scan
The refined approach to improve the quality and length of PWM scanned sequences
was to use peak detection with the DNase-seq data to obtain the areas of relatively
strong DNase-seq signal as broad peaks. The detected peaks were used to extract
corresponding DNA sequences which were subjected to PWM scanning using all
TF motifs as before. The high score sites were saved based on similar 100-fold
randomized background scan and pval = 0.001 criterion. The scanned sequence
was extracted from the UCSC genome version hg19 directly and contained no gene
proximity information. After the scanning and thresholding the actual network was
then inferred from the predictions based on their location using hg19 gene annotation
coordinates.
The validation results are collected in Table 4.4. We notice that the refined ap-
proach based on DNase-seq peaks produces much better results in terms of detected
ChIP-peaks than the previous naive method. Especially the percentage of detected
peaks of Sahu and Urbanucci datasets are promisingly high. On the negative side,
the amounts of false positives are quite high indicating a large number of binding
sites being predicted in locations not validated to be AR binding sites in the cells’
measured state.
Also ROC curves shown in Figure 4.2 were plotted to picture the behaviour of
the predictions when PWM score is thresholded. The Figure shows that with higher
PWM score binding sites the ChIP-seq peaks are detected with slightly less false
positives compared to the basic threshold. Still, the enhancement is quite modest
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Table 4.4: DNase peak based PWM scan
Sahu Urbanucci Massie Yu
Detected 209 31 98 228
Percentage of detectable 75.2 79.5 54.1 46.6
True Positives 470 58 237 492
False Positives 5035 5447 5268 5013
and like in the naive case, it seems that no significant benefit in detection quality
can be drawn from the raising of PWM score threshold.
Figure 4.2: ROC curve of DNase-seq peak detection based PWM scan
4.2.3 ENCODE DNase Data
The ENCODE DNase-seq experiment was used to extract DNA sequence corre-
sponding to the area of observed peaks. Results of this approach validations are
collected to Table 4.5. The results seem to be very similar to those using Housheng
DNase data. This suggests the quality and composition of the two datasets are
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Table 4.5: ENCODE DNase peak based PWM scan
Sahu Urbanucci Massie Yu
Detected 213 32 101 234
Percentage of detectable 76.6 82.1 55.8 47.9
True Positives 487 60 246 511
False Positives 5264 5691 5505 5240
similar and truly very minor differences in prediction statistics can be observed. On
average the ENCODE approach seems to predict a few more ChIP-seq peaks. On
the other hand, however, the ENCODE DNase-seq set contains more peaks which
can be seen mostly in increased false positive predictions compared to corresponding
Housheng predictions.
ROC curves plotted by thresholding the PWM scan score are shown in Figure 4.3.
Interestingly, the figure is almost identical to the previous case with the Housheng
data. This probably tells from the similarity of the two DNase-seq signal sets. Since
we observe predictions with almost similarly behaving PWM scores it seems the
likely that the predicted sites are in fact largely the same even though the DNase-seq
data is different. The two DNase-seq datasets should even be expected to be quite
similar since after all they are measured from the same cell type that received similar
treatments. As the numbers of true positives and false positives correspond to each
other rather well between Housheng and ENCODE datasets, these findings together
suggest that in these different experiments the underlying DNase hypersensitivity
patterns are similar.
4.2.4 Millipede Filtered Peak Scan
Although achieving fair detection sensitivity in the previous approach both with
Housheng DNase-seq data and ENCODE data the large fraction of false positives
remained an issue. To answer this problem an attempt to utilize Millipede TF bind-
ing prediction framework was performed. Locations of the candidate binding sites
found in the previous phase were used to collect corresponding DNase-seq signals
in single nucleotide accuracy. The PWM scan scores of these candidate binding
sites along with the DNase-seq signals were subjected to unsupervised Millipede
prediction using the signal mode "M2" which was suggested in the original publica-
tion. The resulting Millipede scores were used to filter the candidate binding sites,
choosing only those sites with the best Millipede score.
Since the Housheng and ENCODE datasets were noticed to perform almost iden-
tically, only one of these was chosen for the Millipede filtering. Having produced
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Table 4.6: DNase peak based PWM scan
Sahu Urbanucci Massie Yu
Detected 101 15 59 115
Percentage of detectable 36.3 38.5 32.6 23.5
True Positives 151 19 89 156
False Positives 985 1117 1047 980
slightly less false positives the Housheng dataset was selected. Millipede filtering
was observed to lower significantly the number of predicted binding sites in chromo-
some 20 for AR. For example, with the Sahu dataset the number of predicted sites
was reduced from 5506 to 1137. The validation results of Millipede filtered binding
predictions are collected to Table 4.6.
We notice that the Millipede filtering indeed functions as a tool in reducing the
false positives as the number of these drops roughly to one fifth compared to the
unfiltered predictions. However, also the number of true positives drops as the
Figure 4.3: ROC curve of ENCODE DNase-seq peaks based PWM scan
4. Results and Discussion 47
method filters out also correctly predicted binding sites. The ratio of the reduced
true and false positives seems to give a slight positive signal for the filtering: for
example with the Sahu dataset, while the number of correctly predicted ChIP-seq
peaks reduced approximately 56%, simultaneously the number of false positives was
reduced 80%. This indicates the Millipede logistic regression model seems to be able
to reduce the number of false positives more than it loses real binding sites. However,
the benefit achieved by this method is still modest in the sense that we do lose almost
half of the true positives in the process raising questions if the Millipede-assisted
filtering worth its while.
Also a set of ROC curves presented in Figure 4.4was again drawn by thresholding
the PWM scores. The ROC curves resemble largely the corresponding curves before
Millipede filtering. The Urbanucci dataset behaves slightly differently in validation
than before yielding higher area under ROC curve. Also the form of the curves is
lightly affected by the filtering: at FPR 0.5 other than the Urbanucci set show some
worse performance than before filtering. Even though the changes are minor they
prove that the Millipede filtering seems to indeed pick binding predictions based
on the DNase signature, resulting into a differently distributed set of filtered PWM
scores.
4.2.5 Tolerance Inspections
To see whether the missed ChIP-seq peaks were only close misses or far away from
our predictions the candidate binding sites were next allowed different tolerances.
The tolerance was added to each of the predicted sites on both sides so the binding
site was widened two times the tolerance length. The resulting amounts of explained
ChIP-seq peaks were collected to Table 4.7.
Table 4.7: AR prediction covered ChIP-peaks in chromosome 20 with varying tolerance
+/- 0 +/- 50bp +/-100bp +/-500bp
Housheng 227 227 237 277
ENCODE 213 231 240 280
Housheng Millipede 101 111 115 151
ENCODE Millipede 90 99 103 132
As can be seen from the table, expectedly the number of detected ChIP-seq
peaks steadily increases as tolerance is let grow. In general, all experiments seem
to benefit from the increased tolerance but the increase in detected peaks is mostly
quite small. Increasing the tolerance slightly by +/- 50bp the most advantage is
gained by the ENCODE approach without Millipede where the number of detected
peaks rises almost 20 pieces, while the Housheng data without Millipede filtering
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does not detect any new peaks. Notably, the Millipede unfiltered approaches reach
very high prediction fractions as the tolerance is risen to +/- 500bp. However, this
number is unrealistically high, which is given away already by the fact that the
ENCODE approach detects 2 peaks more than were judged detectable based on the
PWM scanning score threshold previously. That is, the tolerance turns the intervals
so wide that they start to overlap some of the undetectable peaks also.
Generally, it seems that some of the detectable but missed ChIP-seq peaks are
located in the proximity of predicted peaks and could be near misses. The fraction
of these cases is still so small, though, that with a realistic tolerance the increase
in prediction performance is only minor. Also from Table 4.8 can be seen that no
significant descent is observable in the number of false positives when increasing
tolerance to +/- 100bp. This suggests the predicted binding sites deemed as false
positives are not in the proximity of the true positive sites but instead divided more
evenly across the whole chromosome.
Figure 4.4: ROC curve of Millipede filtered Housheng DNase-seq peaks
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Table 4.8: Predicted AR binding sites at different tolerances
TP, 0bp FP, 0bp TP, 100bp FP, 100bp
Housheng 535 4870 597 4808
ENCODE 448 5264 619 5132
Housheng Millipede 151 985 182 954
ENCODE Millipede 133 871 157 847
4.2.6 Adjusted Thresholding
To determine truth about the suspicions that too strict PWM score threshold had
initially been used the PWM scanning was repeated for the AR binding motif using
a filtering threshold of p = 0.01 visualized also in the previously shown histogram in
Figure 3.2. The sequences-to-be-scanned were selected from the detected DNase-seq
peaks in Housheng data. The results show that on genome-wide level a staggering
amount of 2, 072, 846 candidate binding sites were approved, 47, 755 of these in
chromosome 20.
As based on the vast number of predictions it seemed unprobable that this ap-
proach would provide major benefit, only one ChIP-seq dataset (Sahu) was used for
a quick validation experiment. With the lowered filtering criterion in mind the DNA
sequence of the ChIP-seq peaks was again inspected for PWM scores and it turned
out that with the criterion p = 0.01 which corresponded to PWM score 6.3 ∗ 10−10
a total of 445 ChIP-seq peaks contained at least one binding site with PWM score
this high.This means that only 4 of the ChIP-seq peaks remain undetectable and
the new prediction set should be able to find almost all of the ChIP-seq peaks, at
least if the DNase-seq signals are suitable.
The almost fifty thousand predictions were matched to ChIP-seq peaks which
resulted in 310 detected peaks and in total 3425 true positive predictions while
producing 44329 false positive predictions. These results when compared to the
earlier results give an unpleasant picture of the effect of lowering the PWM scan
threshold: as the number of true positives grows about 7 times larger compared to
the results of the stricter filtering, the number of false positives is approximately 9
times greater than in the corresponding strict filtering results. This seems to suggest
that the lowered threshold adds more false positives to the predictions than what
can be gained in true positives questioning the usability of the lowered threshold. A
ROC inspection was ignored since it has been clearly demonstrated that the PWM
score thresholding does not have a positive effect on prediction accuracy.
To see if advanced filtering would show any benefits with the increased prediction
size, Millipede filtering with same settings as before was run. The approach reduced
the set of candidate binding sites to 12, 292. The number is approximately 10
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times the corresponding number of predictions with the stricter PWM scan filtering
criterion. This means the Millipede filtering as also the whole DNase-seq peak
detection based PWM scan seems to be linearly scalable as no extra benefit is
gained from the filtering even though the number of candidate binding sites rises.
The resulting set of candidate sites predicted 268 of the 445 detectable ChIP-seq
peaks meaning a better result than the analyses with the stricter criterion. Also the
fraction of detected peaks found after and before Millipede filtering is now higher
than in the stricter criterion (where we had 101 and 227 detected peaks, respectively)
suggesting that the Millipede filtering might be able to extract some more correct
information as the number of predictions increases. The cost of this in terms of false
positives was 11308 while 983 predictions were categorized true positives.
In general, it must be stated that no notable benefits were to be gained by using
a looser PWM score filtering criterion. The number of predictions rises this way to
a highly unrealistic amount and as no efficient way of filtering these for the correct
positions, the results are hardly more usable than those of the stricter filtering
criterion. Still, it has to be admitted that this is the only way of being able to detect
almost all of the ChIP-seq peaks. However, questions whether we even should detect
the peaks in these quite low-scoring areas remains open.
4.2.7 Comparison with Native Unsupervised Millipede
Altogether the so far observed results clearly indicate it is not easy to distinguish the
"true" binding sites of the AR indicated by the ChIP-seq peaks among false positive
predictions. Indeed, it was considered whether this is even possible at all. The sites
deemed false positive are according to the method sites of quite high affinity to AR
and on areas of open chromatin. As discussed in the Chapter 2, the binding of the
TFs is far from a deterministic process but instead the binding frequency depends
on numerous factors. Interestingly it was also discussed that the binding of TFs
is not even directly related to the concentration of the TF in the cell. Thus, it
could be fairly possible that due to some more complex protein-protein interactions
some of the open high affinity binding sites are just left empty: they could easily
have another TF or other protein nearby which inhibits binding of extra elements to
their general proximity. To see whether this is truly the case the whole sequence of
chromosome 20 was subjected to basic PWM scanning and all the resulting PWM
scores were passed along to Millipede along with corresponding DNase-seq signals.
Since Millipede had been shown to perform admirably in previous studies even in
its unsupervised mode the predictions generated by Millipede could be considered
’reliable’, and it’s results would provide more information of the behavior of these
different methods.
The resulting scores from the Millipede run were thresholded allowing only the
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Table 4.9: DNase peak based PWM scan
Sahu Urbanucci Massie Yu
Detected 33 1 3 16
True Positives 441 13 45 205
False Positives 2017 2445 2413 2253
highest scores to be interpreted as candidate binding sites. The choice of this thresh-
old was somewhat arbitrary, but the resulting number of 2458 predictions using the
strictest score did not encourage to selection of a lower criterion. These predictions
were compared with the ChIP-seq peaks and the results were collected to Table 4.9.
Surprisingly, with this strict filtering the numbers of correctly predicted ChIP-peaks
are very low for all datasets. When examined more closely the high scoring Millipede
predictions were found to consist of the highest scoring PWM scan results which
had also adequate DNase-seq signal, that is, the high PWM score seemed to be em-
phasized in the results and the DNase-seq signal was used more loosely. This is the
case using the suggested default parameters with the Millipede logistic regression
model. The weights could likely be adjusted so that at least some differences in the
predictions could be observed but this tuning was left outside of the scope of this
thesis.
The Millipede method, using suggested binning and default weights for DNase-seq
signals and PWM scores produces a high number of predictions that hit relatively
small areas in the genome, as for example in the case of the Sahu dataset, 441 pre-
dicted binding sites were condensed in only 33 ChIP-seq peaks. We hypothesize this
is due to different approaches in the DNase-data usage: when confronting an island
of high DNase-seq signals the Millipede is free to select each site with high PWM
score as a very probable binding site, thus giving it a maximum score. However,
our DNase-seq peak based method is forced to PWM scan only the sequences of
relatively short peaks which apparently yields smaller number of high scoring PWM
scan results. This leads to smaller number of predictions with wider location range.
It seems thus probable that the Millipede prediction could lead into most accurate
coverage of the ChIP-seq peaks if the Millipede result score threshold was lowered
enough. This would be done, however, with a price of false positive explosion.
4.3 Gene Proximity Filtering
The binding sites of TFs occur frequently in gene promoters and promoter proxi-
mal regions since these are the main areas of transcriptional control. With this in
mind the number of false positives predictions was inspected by thresholding the
predictions based on gene proximity. Distances of each predicted binding site were
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calculated to each genes TSS and the minimum distance was selected as a ’gene prox-
imity’ score.These scores were then thresholded to produce the ROC curves showed
in Figure 4.5. When compared to PWM scan score thresholding the proximity fil-
tering produces clearly different results. It seems that the gene proximal regions are
covered with nearly equal amounts of false positives and true positives providing
no help in their distinction. As the distance to gene TSSs grows it seems to con-
tain some information capable of predicting more true positives than unthresholded
version. In addition, interestingly on long distances to TSSs the predictions seem
to be exclusively false positives. This suggests that the TSS proximity information
could be used to filter out those false positives that exhibit the longest distances.
Doing this effectively would however require more studying since a method for some
distance threshold determination should be devised. Also, on short distances it is
apparent that no major benefit is to be gained from this filtering scheme.
Figure 4.5: ROC curve of gene proximity thresholding
4. Results and Discussion 53
4.4 Predicted Network Inference
Based on the previous analyses in seemed that the performance of Housheng DNase-
seq and ENCODE DNase-seq was quite similar. The Housheng data set seemed
to detect slightly more ChIP-peaks and it was selected for visualization. First, a
loosely constructed network including all candidate promoter and enhancer sites was
inferred by stating that all predicted binding sites located 250kb upstream of a gene
promoter are candidate regulators for the gene. The resulting network consisted of
approximately 3.5 million regulation connections between TFs and genes, which on
average translates into over 5, 000 regulated genes for each TF. When examining, for
instance, the AR targets the predictions state that nearly 10, 200 genes are regulated
by AR - an amount that seems rather excessive.
Also a more strict network construction with predicted regulation connections
overlapping 1000bp sequences upstream of TSSs was also performed. The resulting
network contained approximately 1.1 million connections between different regula-
tors and targets. Even though the amount of connections drops the change is not
dramatic. This is hyphotesized to be caused of the great number of false positive
predictions showing regulation connections also there where they do not exist. Al-
though principally fully visualizable, this network is still too large for a sensible
visualization and the imaging of the networks was ignored here.
4.5 Gene Expression Enriched Networks
It appears that the prediction methods used have been able to produce a network
of putative regulation connections in LNCaP cells given their current state. Clearly
according to our ChIP-seq validations not all of these predicted connections are
present in the cells making the network too ambiguous to be used as a stand-alone
tool. To compare, validate and refine our predicted regulation network gene expres-
sion microarray data was used to enrich the constructed network.
The gene expression data created originally by Massie et al. consisted of a time
course measurement of DHT treated LNCaP cells against ethanol treated controls.
From the time series expression of steady state and 4 hour measurements were used
aiming to uncover different waves of regulation and picture these as different layers
in our gene regulation network. The data was downloaded from GEO [50] in a pre-
processed form as a text file. The Illumina probe names were mapped to gene names
and quantile normalization was performed to the data to ensure the validity between-
chip comparisons. Differential expression was calculated based on at least two-fold
difference in treated versus control samples and statistical significance shown by
pvalue less than 0.05. [13]
Genes with log2-scale expression under 6 in the steady state were removed and
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the remaining genes were considered to be expressed. These 9419 genes were used
to filter our predicted Millipede filtered network and as a result a network of 94888
regulation connections was obtained, reducing the number of connections substan-
tially approximately to 8% of the original number. However, even this network is
still much too large for sensible visualizations so network images were not produced.
Of the almost 100, 000 putative regulation connections of the previous network
1303 genes were claimed to be under AR regulation. The amount seems still quite
large and still reflects the observed great numbers of false positives likely resulting
into false connections. The differentially expressed genes at 4h in the gene expression
measurement were extracted resulting in 23 genes which were all observed among
the predicted targets of AR and thus among the 1303 genes mentioned above. The
expressed targets of these genes were also obtained and the resulting two-level AR
downstream network contained a total of 12984 regulation connections.
As this large network, although visualizable, cannot be presented in the text in a
clear way, instead a very simple two-level network of predicted AR targets deemed
differentially expressed by the microarray data analysis at 4 hour time point was
illustrated. AR known target KLF5 [60] was identified from the predictions and
from differentially expressed genes, and it was visualized with five of its predicted
and differentially expressed targets to Figure 4.6. The genes are colored according
to their differential expression, brighter red indicating larger difference. This visual-
ization is a simple example of what kind of local network inference can be performed
with the predicted network and gene expression data.
Figure 4.6: Two-level downstream regulation induced by AR
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5. CONCLUSIONS
In this work computation prediction of TF binding using PWM scanning was merged
to DNase I sequencing data in an attempt to create reliable predictions of regulation
connections and, ultimately, a genome-wide gene regulatory network in LNCaP cells.
The aim was achieved in the sense that all necessary tools needed for the process,
what we could call ’de novo regulome assembly’ from predictions, were either created
or presented. The attempt was finally led to a conclusion by generation of gene
expression information enriched global regulation network and AR downstream two-
layer network.
The validation ChIP-seq datasets were shown to be solid performers throughout
the work when compared to one another. Despite having very different amounts
of peaks the sets showed mainly very consistent behaviour in ROC curves and in
true positive predictions. The most notable exceptions were in validating the per-
formance of DNase peak based PWM scans where 75%-80% of Sahu and Urbanucci
datasets could be explained while only 46%-54% of Massie and Yu sets were pre-
dicted correctly. The differences in the case of the Yu set were thought to be caused
by the different treatment of cells as they were cultivated in androgen-rich environ-
ment for several hours longer than in other experiments.
From the very first results with the naive DNase-seq utilization it became clear
that the most challenging part of the approach is to find a way to effectively reduce
the number of false positive predictions. Extensive efforts were made to overcome
this challenge through various developed methods and new ideas. Compared to
control ChIP-sequencing peaks the examined methods performed fairly, at their
best explaining 75% of the ChIP all detectable peaks. However, despite these various
efforts the false positive issue remained a dominating feature in all prediction types.
The reasons why the remaining portion of detectable peaks was not detected
remains as a subject for speculations. It can very well be that some unfortunate
patterns in DNase-seq signal or in the peaks detected from it gaps exist in crucial
locations, preventing the detection. In future developments clearly the role of peak
detection must be investigated further, it being one of the few aspects not covered
in this thesis. As the peak detection affects directly the scanned sequences in other
approaches than our naive starting point, different peak calling algorithms would
surely have an impact on the prediction results.
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Another interesting question is the proportion of ChIP-sequencing peaks that
were deemed undetectable due to their location in areas of low PWM scores. Here
most probably a balance of ChIP-sequencing biases, peak detection issues and ef-
fects of indirect regulation together form the observed behavior. Like all experi-
ments, ChIP-seq is susceptible to many measurement errors, and the peak detection
algorithms used, although nowadays very developed, have to in practice deal with
noisy datasets of varying quality. Experiment and analysis related errors are thus
always prone to exist and explain part of the undetectable peaks. Another major
reason already shortly discussed in the results is the tendency of TFs to function in
protein-protein interaction complexes. This leads to regulation control which does
not require DNA binding from all subunits of the complex making sites these sub-
units impossible to detect at these locations with DNA sequence scanning methods.
However, as ChIP-seq experiment may very well detect such complexes and corre-
sponding sequence is reported as response element to also those proteins not actually
binding the DNA. The inability to take into account indirect regulation is a clear
weakness of all DNA sequence scanning based methods with no apparent solution.
Keeping the aforementioned in mind it must be emphasized here that the rea-
sonability of the performed validations depends critically on the available ChIP-seq
dataset and all the reported results also in this thesis are valid only so far as the
ChIP-seq data can be judged trustworthy. This means that dividing the prediction
results directly into ’right’ and ’wrong’ or true and false predictions is somewhat
unrealistic as the cell as a dynamic environment is a subject to constant varia-
tions and the regulation patterns may quickly be altered. The so called ChIP-seq
ground-truth is always a snapshot of the cell in one condition and is thus never
alone capable to picture the all regulation connections even in same cell type and
similar conditions. ChIP-seq can, however, be considered as a rather trustworthy
method in determining at least what connections are present making it a fine tool
for validating our predictions as long as the here mentioned limitations are kept in
mind when interpreting the results.
Some simplifications had to be made in the method construction and validations
and these need to be given more attention in future developments. The selection
of initial filtering criterion for PWM scan scores is somewhat arbitrary since no
guidelines and no apparent testing method existed at the point when the choice
had to be made. As noticed in the validations, however, the original seemingly
strict filtering criterion seemed actually to have been a quite reasonable choice, as
lowering the criterion was shown to explode the number of false positives without
clear benefits in detection. Another clear simplification is the excessive use of AR in
PWM scan score threshold assessment and in all validations. This special role for
AR in this thesis was partially forced and partially wanted choice. As a key regulator
5. Conclusions 57
in prostate cancer AR is an interesting target for the information revealed by the
validations and, later, the gene regulatory network construction. Also since AR has
been a subject for intensive study a multitude of datasets mapping its characteristics
exists and are freely available. This largely enabled the broad inspections presented
in this thesis in the context of different ChIP-seq set comparisons, DNase-seq data
comparisons and utilization of time course gene expression data. This positive factor
is in the same time the reason for forced selection of AR as our main target molecule:
not as excessive datasets exist for other factors.
According to earlier published work the Millipede and Centipede produce highly
more accurate results than the methods reviewed in this work. However, these
methods typically utilize PWM scanning and DNase-seq signals but require also
ChIP-seq inputs for best performance our approach has certain clear advantages.
Since ChIP-sequencing data is not available for even nearly all transcription factors
in all common cell types the methods utilizing it are futile when it comes to whole
genome-wide regulome assembly. This is why further development of our approach
is potentially very interesting due to its general nature.
The future prospects of these types of approaches attempting prediction based
regulome assembly is somewhat open. While potential applications of reliable genome-
wide regulation networks in human cells are intriguing, the challenges on the way
in achieving this goal are still considerable. However, we can fairly comfortably
state that such attempts will be seen in the future more often and hopefully also
with developed methods. Still, to which extent this direction of research is pursued
remains a mystery.
The presented work is a thorough exploration of steps required for prediction
based regulome assembly. While producing fair results perhaps its most value lies in
the knowledge of approaches that do not result improvements in detection precision
so that these can be avoided in the future. Altogether the thesis forms a solid
foundation for future studies aiming to pursue even more ambitious goals in the
field of computational prediction of regulation.
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